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“ 
 
“Seeing, contrary to popular wisdom, isn't believing. 
It's where belief stops, because it isn't needed any more.” 
Pyramids, Terry Pratchett 
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2 Abstract 
Atherosclerosis results from a progressive accumulation of lipids in the arterial intima 
leading to plaque formation. Epidemiological studies show an inverse association of high 
density lipoprotein (HDL) cholesterol with cardiovascular events. HDL and its main 
apolipoprotein A-I (ApoA-I) have multiple anti-atherogenic functions. Some of them are 
exerted within the vessel wall, notably the classical function of HDL, namely the mediation 
of cholesterol efflux from macrophage foam cells. To get access to the intima and the 
lipid-laden macrophages, HDL has to pass the endothelial barrier. Previously, we showed 
that ApoA-I transcytosis is modulated by ATP binding cassette transporter (ABC) A1, and 
HDL transcytosis is modulated by ABCG1, scavenger receptor B I (SR-BI) and endothelial 
lipase (EL).  
To elucidate the itinerary of ApoA-I and HDL through endothelial cells (ECs), we 
investigated the cellular localization of ApoA-I and HDL, which was labelled either 
fluorescently, or with 1.4 nm Nanogold by using fluorescent microscopy and electron 
microscopy (EM), respectively. For EM, we used high pressure freezing to avoid artefacts 
and lipid extraction. Nanogold was detected by silver enhancement after fixation in OsO4.  
HDL as well as ApoA-I are taken up by ECs, and ApoA-I and HDL co-localize indicating 
the same route of trafficking. We compared the trafficking of ApoA-I and HDL with 
Transferrin and Albumin, which were used as tracers for clathrin- and caveolin-mediated 
endocytosis, respectively. Both pathways showed partial colocalization indicating a non-
classical pathway for HDL trafficking. 
Further experiments showed that HDL is targeted neither to lysosomes nor to the Golgi 
nor to the endoplasmatic reticulum. Only a small amount can be detected in early 
endosomes (Rab5) and endosome to trans-golgi network (Rab9), but not at all with late 
endosomes (Rab7), the recycling endosomes (Rab11a) or vesicles involved in trans-Golgi 
network sorting (Syntaxin6). EM ultrastructure showed HDL to be located mainly in 
multivesicular bodies.  
We performed pharmacological inhibitions and found that HDL uptake is cytoskeleton 
dependent but only weakly affected by blocking the fluid phase uptake with Amiloride or 
EIPA. Neither did we observe any colocalization of HDL with dextran as the marker of fluid 
phase uptake. 
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HDL was found to stimulate its own uptake into ECs. We identified several HDL and/or 
ApoA-I induced changes in the phosphorylation of signaling molecules, which however still 
remain to be linked to HDL endocytosis.  
In conclusion HDL transport into and through ECs seems to follow a non-classical 
trafficking route. It appears to be regulated by positive rather than negative feedback..  
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3 Abstrakt 
Atherosklerosis entsteht durch eine fortschreitende Anhäufung von Lipiden in der Intima 
von Blutgefässen und trägt somit zur Entstehung von Plaques bei. Epidemiologische 
Studien zeigten eine negative Korrelation vom Lipoprotein hoher Dichte (high density 
lipoprotein - HDL) mit kardiovaskulären Ereignissen. HDL und dessen primäres 
apolipoprotein A-I (ApoA-I) haben vielfache anti-atherogene Funktionen. Einige davon 
können nur in im Inneren der Blutgefässwand stattfinden, insbesondere die Abführung von 
Cholesterin aus den Schaumzellen-Makrophagen innerhalb der Intima. Um dahin zu 
gelangen, muss aber HDL die endotheliale Barriere überqueren.  
Vorhergehend haben wir gezeigt, dass die Transzytose von ApoA-I durch den ABC-
Transporter A1, und die Transzytose von HDL durch ABCG1, Scavenger Receptor B I 
(SR-BI) und die Endotheliale Lipase (EL) moduliert sind. 
Um die Route von ApoA-I und HDL durch die Endothelzellen (ECs) aufzuklären, haben wir 
die zelluläre Lokalisation von ApoA-I und HDL studiert, welche wir entweder mit 
Fluoreszent-Farbstoffen oder mit 1.4 nm Nanogold markiert haben für Fluoreszenz- und 
Elektronenmikroskopie (EM). Für EM haben wir die Proben durch Hochdruckgefrieren 
präpariert um Artefakte und Lipidextraktion zu minimieren. Nanogold haben wir dann 
mittels Silberverstärkung direkt nach der Fixation in OsO4 für das EM detektierbar 
gemacht. 
Sowohl HDL als auch ApoA-I werden durch ECs aufgenommen und co-lokalisieren 
miteinander, deutend auf die gleiche Route. Wir haben den Transport von ApoA-I und 
HDL mit Transferrin und Albumin verglichen, welche stellvertretend waren für die  
Clathrin- and Caveolin-mediierte Endozytose. Beide zeigten partielle Co-Lokalisation, was 
auf einen nicht-klassischen Pfad für HDL deutet.  
In weiteren Experimenten zeigten wir, das HDL weder in Lysosomen, noch ins Golgi oder 
das endoplasmatische Retikulum geht. Nur ein kleiner Anteil kann in frühen Endosomen 
(Rab5) und Endosomen-zu-Trans-Golgi-Netzwerk (Rab9) detektiert werden. Es findet sich 
jedoch kein HDL in den späten Endosomen (Rab7) und rezyklierenden Endosomen 
(Rab11a) oder im Trans-Golgi-Netzwerk Sortiervesikeln (Syntaxin 6).  
Im EM finden wir HDL primär in multivesikulären Körpern. Wir haben dann 
pharmakologische Inhibition durchgeführt und fanden HDL Aufnahme in ECs benötigt ein 
funktionierendes Zytoskelett. HDL geht vermutlich nicht via Flüssigphasen-Aufnahme in 
die ECs, weil Amiloride und EIPA wenig Effekt hatten und HDL auch nicht mit 
Flüssigphase-Markern wie 40 kDa Dextran co-lokalisiert. 
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Weiter fanden wir, das HDL selber die eigene Aufnahme in ECs positiv beeinflusst.  Wir 
identifizierten diverse HDL und/oder ApoA-I induzierte Veränderungen in der 
Phosphorylierung von Signalmolekülen, welche wir jedoch noch nicht in direkten 
Zusammenhang mit Endozytose bringen konnten. 
Zusammenfassend kann festgehalten werden, dass HDL Transport in und durch die ECs 
einen nicht-Klassischen Weg geht und positiver statt negativer Selbstregulation unterliegt.  
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4 Introduction 
4.1 The circulation system and endothelium  
According to the roman physician Claudius Galenus (129-200), inhaled and exhaled air, 
nutrients, and blood all flow through the same blood vessels. He and his contemporaries 
believed that the vascular system of the human body is open ended. The heart was 
considered to be the exchange point of the two tubing systems, which provide all organs, 
provided with gas and nutrients.  
Andreas Vesalius (31 December 1514 – 15 October 1564), William Harvey (1 April 1578 – 
3 June 1657) and others realized that the blood system is not open. They observed that 
the heart septum is tight and closed and thereby precludes any option of fluid exchange 
between the two tubing systems. They also discovered valves in the veins but not in the 
arteries and thereby discriminated the two different systems. Interestingly their circulation 
model was accepted generally only after lenses and microscopes were developed and 
allowed to visualize the microvasculature and their connections throughout the body.  
Although Galenus, Hippokrates, and their contemporary colleagues were wrong with their 
assumption of an open blood system rather than a circulation, they correctly referred to 
the importance of arteries and veins for the regulation and maintenance of body 
homeostasis.  
The closed circulation model (shared by all vertebrates) adds complexity to the model of 
Galenius by not allowing the blood components to leave freely into the extravascular 
space of organs.  
Xavier Bichat and Wilhelm His attempted to map all membranes of the human body and 
specifically focused on developmental stages. The formation of cavities in the 
differentiating mesodermal tissues resulted in inner “membranes”, which could not be 
called epithelia since they formed the inner rather than outer surfaces. Therefore they 
termed these membranes “endothelia” (His 1865). Later Waldeyer (Waldeyer 1900) 
excluded all the other “thelia” derived from the mesoderm which do not develop into the 
innermost layer of blood and lymp vessels (and the posterior lining of the cornea).  
Later electron microscopy studies (Hibbs et al. 1958; WEIBEL & PALADE 1964) showed 
variation in the structure and function of capillaries and arterioles. The endothelium adapts 
structure and function site specifically to the niche it is residing in. When removed from 
their native niche either by vessel transplantation or by in vitro culture, endothelial cells 
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(ECs) undergo phenotypic drift (Sandow & Grayson 2009) and lose many of their original 
properties and acquire new ones, depending on the signals they are receiving.  
ECs develop from the mesoderm and are the driving force in vascular development and 
maintainence as well as reactants to exceptional situations. Both endothelial progenitor 
cells and differentiated endothelial cells drive vasculogenesis, i.e. the formation of new 
blood vessels during embryonic development, and in later life revascularization and 
angiogenesis, i.e. the expansion of blood vessels. These processes directly influence 
organ development which in turn feeds back to the specialization and fine tuning of EC’s 
according to their niche (Weinstein 2002; Nikolova & Lammert 2003; Park et al. 2013).  
Once the blood vessel is completely formed, angiogenesis and vasculogenesis are shut 
down. The ECs are then maintaining the vessel by lining the lumen and forming a smooth 
surface containing heparan sulfate and other proteoglycans which inhibit coagulation and 
thrombogenesis by activating antithrombin (Teien et al. 1976; Marcum & Rosenberg 1984; 
Shimada & Ozawa 1985) . Further the ECs are crucially involved in blood pressure 
regulation by inducing vasodilation in response to acetylcholine and other vasoactive 
hormones (Chand & Altura 1981).  
ECs also play a central role in the immune system (Pober & Sessa 2007). Of particular 
importance, the endothelium regulates the migration of leukocytes from the blood into the 
tissue (Wautier et al. 1990). To do this, the endothelium actively allows binding of 
leukocytes to endothelial cells by receptors, which elicit opening of intercellular junctions 
and thereby allow blood borne cells to pass the endothelial monolayer into the tissue or 
subendothelial space.  
The protein family of tetraspanins associate with several transmembrane proteins forming 
microdomains involved in intercellular adhesion and migration. Intercellular adhesion 
molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) act as receptors 
mediating leukocyte adhesion and transendothelial migration (Barreiro et al. 2005; 
Barreiro et al. 2008) in which also the endothelial glycokalyx is playing an important 
function (Mulivor & Lipowsky 2002). 
The barrier as such is therefore an active and highly regulated function exerted by the 
endothelium. 
 
4.2 The endothelium as an active barrier  
The endothelium is a very dynamic and selective barrier and its permeability is highly 
regulated under physiological and pathological conditions. The integrity of the monolayer 
12 
depends on the cytoskeleton and cell-cell interaction complexes as well as the interaction 
with the extracellular matrix on both the basolateral and luminal sides of the vessel.  
Adherent junction complexes separate the basolateral and luminal plasma membranes. 
They hinder uncontrolled movement and mixture of these two membranes and thereby 
trigger the polarization of the ECs and establish the closed monolayer.  
During development the triade of cerebral cavernous malformation 1 (CCM1), VE-cadherin 
and Rap1 define the vascular lumen and polarization of ECs (Lampugnani et al. 2010). 
The selectivity of the endothelium is regulated in three layers: First, the extracellular matrix 
consisting of a thick complex glycokalyx (Ebong et al. 2011) directly exposed to the blood 
flow;  second, the endothelial cells forming a tight monolayer with cell-cell junctions; and 
third, the basal matrix and together with the intima. The glycokalyx is a steric filter (Levick 
& Michel 2010) as well as an interaction platform for a variety of enzymes, which modulate 
and interact with other molecules in the blood stream.  
The endothelial cell monolayer enables the fast and highly flexible modulation of 
permeability. For allowing anything to pass the endothelium, the ECs have either to open 
membrane channels, or disassemble adherent and tight junctions or to take up the 
molecule by endocytosis for intracellular transport and secretion on the basolateral site. 
Channels – for example aquaporins – allow transport through the luminal and basolateral 
plasma membranes (Levick & Michel 2010). Paracellular transport – for example of 
monocytes - is regulated by opening and closing of tight and adherence junctions. Finally 
vesicles allow transcellular transport of cargo between the luminal and basal plasma 
membranes.  
4.3 Endocytosis 
Every cell has the ability to take up material from the environment or niche it is residing in. 
Uptake mechanisms have developed several times during evolution so that a variety of 
independent and sometimes redundant mechanisms have emerged. Phagocytosis 
describes the uptake of entire organisms, for example bacteria by macrophages. 
Pinocytosis is a receptor-independent pathway resembling to drinking of surrounding 
liquids. Endocytosis is the uptake of extracellular molecules into intracellular vesicles by 
receptor membrane domains of protein complexes. As the general principle, the cargo is 
engulfed into a vesicle, which is pinching off from the plasma membrane.  
Clathrin coated vesicles were the first distinct structures detected by EM (Friend & 
Farquhar 1967) and classified as such (Pearse 1976). The process of clathrin dependend 
endocytosis was studied in detail and led to the idenfitication of adapter proteins (Pearse 
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& Robinson 1984) which bridge the clathrin coat to the receptor or platform binding the 
cargo (Sorkin 2004). 
All other endocytotic events are primarily classified as clathrin-independent. However, it is 
much more difficult to address them, since unlike clathrin coats they cannot be 
distinguished by EM and since the cell has hundreds of different vesicular machineries 
which we are still beginning to understand. Caveolae (Yamada 1955; Palade & Bruns 
1968) were early observed by shape, but it took some time to identify the most prominent 
proteins associated with them, the Caveolins Cav1, Cav2, and Cav3 (Rothberg et al. 
1992) and even longer to identify their origin in the plasma membrane and thereby their 
involvement in endocytosis (Schnitzer et al. 1995; Schnitzer et al. 1996). The albumin 
receptor GP60 was identified as the first one mediating cav1 dependent endocytosis 
(Vogel et al. 2001). Only recently the first “adapter protein” in the cav1 dependent 
endocytotic pathway was unrevealed. KIF13b recruits the LDL receptor like protein 1 
(LRP1) into caveolae for association with cav1 and uptake of LDL (Kanai et al. 2014).  
Dynamin 1 is needed to pinch off both clathrin-vesicles and cav1 vesicles from the plasma 
membrane, whereas dynamin 2 contributes to plasma membrane invaginations involved in 
fluid-phase micropinocytosis (McClure & Robinson 1996; Sweitzer & Hinshaw 1998; Cao 
et al. 2007). There are also clathrin and dynamin independent carriers (CLICs) (Kirkham 
et al. 2005), which may end up into glycosyl phosphatidylinositol-anchored proteins 
enriched in early endosomal compartments.  
With some exceptions (for example diphtheria toxin) the cholesterol content of the plasma 
membrane is an important determinant of endocytosis by modulating membrane fluidity 
(Skretting et al. 1999). Furthermore, some GTPases like CDC42, RhoA or ARF6 
(Schweitzer et al. 2009; D’Souza-Schorey & Chavrier 2006) regulate endocytosis of some 
cargo by recruitment of coat proteins, modulation of lipid composition and actin filament 
formation at the plasma membrane. Only recently has been shown that the ARF6 
exchange factor (EFA6) interacts directly with endophilin at the plasma membrane to 
modulate clathrin-mediated endocytosis (Boulakirba et al. 2014).  
4.4 Targeted sorting inside eukaryotic cells 
Once internalized, the cargo is transported within a vesicle, which either fuses with a 
target membrane for the release of the cargo or hands the cargo over to another acceptor. 
The specificity of a trafficking route through the cell is organized in a modular set-up. 
Vesicles contain complexes, which associate with dyneins or kinesins to transport the 
vesicle along microtubules either towards or away from microtubule organizing centers or 
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centrosomes. On the way across the cell they encounter different membranes, which they 
may or may not interact with.  
The membrane identification and interaction is mediated by GTPases of the Rab/Arf, Ral 
and Rho family (Zerial & McBride 2001). The Rabs define the identity of a membrane. 
About 70 different Rabs exist in mammalian cells. Some of them are tissue and cell 
specific others are more ubiquitously expressed.  Structure and recruited binding partners 
of different Rab-complexes are known (Khan & Ménétrey 2013).  
The control of fusion of a membrane with another is triggered by SNARE (Soluble N-
ethylmaleimide-sensitive factor attachment protein receptor) proteins about 60 of which 
are expressed by mammalian cells. The SNAREs facilitate fusion. When two opposing 
membranes meet with the correct vesicle-SNARE (v-SNARE) and target-SNARE (t-
SNARE) they form together with the SNAP25 protein the fusion initiation complex (Walch-
Solimena et al. 1995; Jahn & Scheller 2006; Hong & Lev 2014). By its own conformational 
change, this complex is then aiding the two membranes to undergo the conformational 
changes needed for the fusion of the two membranes. This process is calcium dependent 
but it is yet not clear how exactly it happens, as modeling of membrane fusions is difficult.  
Since the t- and v-SNARE nomenclature is purely functional, most of the SNAREs are now 
classified by their structural identity (r-SNARE, q-SNARE for arginine or glutamine critically 
involved in complex assembly). Alternatively they are classified by historical family names, 
for example the syntaxins in mammals).  
4.5 Exocytosis 
For exocytosis, Rabs and SNAREs control the targeting of vesicles to the plasma 
membrane for fusion as described before. Rab3 is directly involved in exocytotic/secretory 
events in neurons (Fischer von Mollard et al. 1994). Syntaxin4 and SNAP23 clustering is 
needed for the fusion with the endothelial basolateral plasma membrane (Predescu et al. 
2005). Exocytosis depends on the plasma membrane cholesterol content. Depletion of 
cholesterol is reducing exocytosis events whereas enrichment with cholesterol is restoring 
function (Rituper et al. 2012). When vesicles fuse with the plasma membrane, the excess 
material is recycled by bulk endocytosis. This maintenance of the plasma membrane lipid 
homeostasis links endocytosis and exocytosis. An exception is the so-called just kiss-n-
run membrane fusion: after release of the cargo the vesicle dispatches entirely from the 
plasma membrane. 
.  
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4.6 Transcytosis 
Any transcellular transport of molecules is termed transcytosis. In general, transcellular 
transport is not well understood although the term was already used 31 years ago in the 
literature to describe transcellular transport in thyroid epithelia (Herzog 1983).  
Williams et al showed for the first time that isolated endothelium is useful to study 
transcytosis of albumin since it reaches a steady state of balancing endo- and exocytosis 
after 40 minutes (Williams et al. 1984).  
The transcytosis of albumin was studied by thin frozen section electron microscopy of 
gold-labelled monomeric albumin perfused through murine lung, heart endothelium and 
diaphragm (Milici et al. 1987; Ghitescu et al. 1986). Monomeric albumin was found to bind 
with low affinity to the luminal surface of the capillary endothelium. After transport in 
plasmalemmal vesicles it appeared in the pericapillary space less than 15 s after starting 
perfusion. The gold-albumin was limited to some microdomains within plasamalemmal 
structures. This indication that albumin is transported by a receptor mediated mechanism 
was later proven by the identification of gp60(Vogel et al. 2001).  
Endothelial transcytosis of low density lipoproteins (LDL) was studied extensively by the 
Simionescu lab. The uptake and transport of LDL was visualized and quantified by 
electron microscopy identifying the dual route of traffic and transcytosis (Vasile et al. 
1983). Their findings in the lung alveolar capillary endothelium indicated that LDL is taken 
up both by a receptor-mediated mechanism into clathrin-coated pits and a receptor 
independent process involving the direct formation of plasmalemmal vesicles, which they 
named “fluid endocytosis”. They stated, that both mechanisms deliver LDL to lysosomes 
for cellular cholesterol supply but that in addition the majority of LDL is transcytosed 
through the endothelial cells to be delivered to other cells in the vessel wall. (Nistor & 
Simionescu 1986) 
Kishimoto et al studied the hepatic trafficking of the Fe-Transferrrin complex and revealed 
that the liver first transcytoses the Fe-Trf complex through its endothelium before uptake 
into hepatocytes (Kishimoto & Tavassoli 1987). Transcytosis is also the process by which 
proteins are shuttled from the circulation across the blood-brain-barrier (BBB) as has been 
firstly shown for Fe-Trf (Fishman et al. 1987).  
Transcytosis of molecules across the BBB has been intensively studied to be exploited for 
drug delivery to the brain. There are attempts to couple the drug of interest to transferrin 
(Yan et al. 2013), colloidal particles (Tucker et al. 2012) or other means (Ghaffarian & 
Muro 2013; Bell & Ehlers 2014). Unfortunately, all these methods are not specific for the 
BBB. It will be important to understand how the endothelia of the different organs 
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specifically regulate transcytosis. For the time being, these new drug delivery systems are 
ways vehicles to penetrate endothelia randomly.  
4.7 Lipoproteins 
The vascular circulation system is transporting the hydrophilic medium called blood. 
Within this aqueous environment hydrophobic molecules can be transported either by 
blood cells (erythrocytes, leukocytes and platelets) or complexed to amphiphilic structures. 
These complexes are called lipoproteins. They contain apolipoproteins, which easily 
associate themselves with phospholipids. These amphiphilic complexes can 
accommodate even more hydrophobic lipids either on the surface (cholesterol) or core 
(triglycerides, cholesterol esters). Thereby conceptually the lipoproteins are platforms that 
enable the otherwise aqueous blood plasma to contain and distribute hydrophobic 
molecules.  
Traditionally, the lipoproteins are classified by their buoyancy upon ultracentrifugation in 
defined density solutions. The more triglycerides they are carrying, the bigger they are and 
also the less proteins they have per total mass of particle. The cutoff densities (Barter et 
al. 2003) and particle sizes (Sakurai et al. 2010) are descripted in Table 1 for the typical 
lipoproteins in humans. Higher resolution into subclasses has been reached by nuclear 
magnetic resonance spectroscopy, non-denaturing gradient gel electrophoresis, or density 
gradient ultracentrifugation. 
 
Table 1: Human Lipoproteins 
 
Density cutoffs 
(g/ml) 
Particle diameter 
(nm) 
Chylomicrons (CM) <0.95 600 – 200 
Very low density lipoproteins (VLDL) 0.95 – 1.006 200 – 80 
Intermediate density lipoproteins (IDL) 1.006 – 1.019 80 – 30 
Low density lipoproteins (LDL) 1.019 – 1.063 25 – 18 
High density lipoproteins 2 (HDL2) 1.063 – 1.125 12 – 9  
High density lipoproteins 3 (HDL3) 1.125 – 1.210 9 – 7.7 
Very high density lipoproteins (VHDL) 1.210 – 1.250 7.7 – 7.0  
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4.7.1 Apolipoproteins 
The major apolipoproteins are structural prerequisites to form lipoproteins, namely ApoA-I 
for HDL, ApoB100 for LDL and VLDL, and ApoB48 for chylomicrons (CM). The typical 
apolipoproteins (ApoA-I, ApoA-II, ApoB, AboC’s and ApoE)  - except apoB – have 
emerged from one ancestral gene during evolution and are characterized by the presence 
of multiple amphipathic alpha-helices and the absence or low-abundance of short beta-
sheets.  In addition to lipid solubilization they exert specific functions like receptor binding 
(ApoB and ApoE) and enzyme activation  (ApoA-I and ApoC-II). In addition to the typical  
apolipoproteins other proteins (for example ApoM, ApoD, ApoH) associate with 
lipoproteins and exert specific functions within and beyond lipid transport and metabolism. 
For example apoM binds sphingosine-1-phosphate (Christoffersen et al. 2012). HDL’s are 
particularly diverse with more than 85 different proteins being associated with (Shah et al. 
2013).A brief overview of the main functions of human apolipoproteins  is given in Table 2.  
 
Table 2: Lipoprotein associations and main functions of apolipoproteins 
Apoprotein  Mw (kDa)  localization Function 
ApoA-I 28 HDL 
Formation of HDL, interaction with HDL 
binding proteins (ABCA1, SR-BI), activation 
of Lecithin:cholesterol acyltransferase 
(LCAT)  
ApoA-II 17.4 HDL Enhances hepatic lipase activity 
ApoA-IV 46 CM, HDL 
Protection of lipids from oxidation, activation 
of LCAT, assembly of CMs 
ApoAV 39 
HDL, VLDL, 
CM 
Facilitates the lipolysis of triglyceride rich 
lipoproteins by LPL  
Apo B48 241 CM Assembly and secretion of CM 
Apo B100 512 LDL, VLDL 
Formation of VLDL and LDL, binds to LDL 
receptor 
ApoC-I 7.6 VLDL, CM Activation of LCAT, inhibition of CETP 
ApoC-II 8.9 VLDL, CM Activates lipoprotein lipase (LPL) 
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ApoC-III 8.7 VLDL, CM Inhibits LPL 
Apo D 33 HDL 
Associated with LCAT, progesterone 
binding 
Apo E (3 
isoforms) 
34 HDL Binds to LDL receptor 
Apo(a) 300 – 800 LDL, Lp(a) 
Linked by disulfide bond to apo B100 and 
similar to plasminogen 
Apo H 38.3 
HDL, CM, 
unclear 
Binds cardiolipin, modulates coagulation  
Apo J 
(clusterin) 
40 
blood 
plasma, milk, 
urine, CSF, 
semen, found 
on HDL, 
unclear if 
others 
Binds immunoglobins, heparin, complement 
proteins, paraoxonase, lipids, various 
functions suggested 
Apo L 
(family with 
7 proteins) 
 
HDL Trypanolytic factor  
Apo M (2 
isoforms) 
21.3 / 13 HDL, LDL 
Isoform 1: binds sphingosine-1-phosphate 
Isoform 2: unclear 
 
4.7.2 Lipoprotein metabolism 
Dietary lipids are absorbed by the epithelium of the small intestine, where they are 
assembled with ApoB48 and ApoE to form CMs. They are released into the lymph. In 
addition CMs carry ApoC-II, which activates lipoprotein lipase (LPL) to hydrolyse the 
triglycerides into free fatty acids and glycerols for uptake and usage by the adipose tissue 
and skeletal and cardiac muscle and for energy storage or production. The remnants of 
the CMs are removed from the circulation by the liver. ApoE plays a key role for efficient 
endocytosis of remnants by hepatic LDL receptor and LRP1 (Brown et al. 1981). 
At low exogenous supply of lipids during periods of fasting, the liver is the main source of 
lipogenesis and lipoproteins to the body. The liver produces VLDL, which contains 
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ApoB100 in addition to ApoC-II, ApoC-III and ApoE. As in CMs, LPL is hydrolyzing the 
triglycerides upon activation by ApoC-II on VLDL. By losing triglycerides and enrichment 
with cholesterol IDL and LDL are formed, which are then cleared by the liver through LDL-
receptor mediated endocytosis. 
4.8 High density Lipoproteins 
The only way the body can get rid of excess cholesterol and other sterols is via the liver 
and bile. Here HDL is believed to play a crucial part as the transporter of cholesterol from 
the periphery back to the liver by a mechanism termed the reverse cholesterol transport 
(RCT) (Norum et al. 1983; Rothblat et al. 1986). However, the HDL cholesterol 
concentration does not reflect the amount of cholesterol undergoing RCT (Hellerstein & 
Turner 2014). Infusions of artificial HDL increased the fecal excretion of sterols.  
Besides just removing cholesterol from macrophage foam cells, HDL plays important roles 
in the redox state of plasma (Yin et al. 2013; Kelesidis et al. 2012), the modulation of 
inflammation (Tabet & Rye 2009; De Nardo et al. 2013; Barter et al. 2004; Navab et al. 
2005) as well as the removal of lipopolysacherides and other endotoxins (Ma et al. 2004).  
For the mediation of cholesterol efflux from macrophages and the delivery of cholesterol to 
hepatocytes but also for various cytoprotective effects, HDL has to cross the endothelium.  
4.8.1 The multitude of potential ApoA1 and HDL receptors  
Receptors for HDL were searched in different cells by different approaches. In one, a 
protein-A-ApoA-I fusion protein was expressed in Escherichia coli and revealed high 
affinity binding to a 110 kDa cell surface protein (Bond & Howell 1987) . The authors 
further indicated that the ApoA-I portion of HDL is responsible for the binding to this cell 
surface protein which was also postulated to be expressed in hepatocytes (Rifici & Eder 
1984).  
Two 110 kDa and 130 kDa proteins were found by ligand blot analysis (Hokland et al. 
1992) to bind HDL. Both seem to be glycosylated. A 95 kDa protein was identified 
(Bocharov et al. 2001) which binds HDL with high affinity and resides mainly inside cells 
since trypsin treatment of cells affect its binding to HDL only by minor degree. Further 
deglycosylation of the hepatocytes used in the study did not abolish the binding 
implicating that glycosylation is not required for the binding to HDL.  
Interaction of HDL with ECs has been studied now since tree decades without yet having 
a satisfactory model. It has been observed that ECs bind and internalize HDL differently to 
LDL.  HDL is not degraded like LDL. Furthermore the binding of HDL can be partially 
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competed by LDL indicating that binding sites are either overlapping or shared (Tauber, 
Goldminz & Gospodarowicz 1981; Tauber, Goldminz, Vlodavsky, et al. 1981).  
4.8.1.1 SR-­‐BI	  
SR-BI was found in Chinese hamster ovary (CHO) cells to work as a scavenger receptor 
for HDL (Krieger 1999; Acton et al. 1996) in addition to LDL, VLDL and a variety of ligands 
such as modified (acetylated or oxidized) lipoproteins, maleylated bovine serum albumin, 
advanced glycation end-product modified proteins, anionic phospholipids, and apoptotic 
cells (Rigotti et al. 2003). It was later verified, that SR-BI is responsible for uptake of HDL 
into CHO cells (Rhode et al. 2004). 
The selective cholesterol and cholesterol ester transport into hepatocytes independently of 
particle uptake is the classical function mediated by SR-BI. Cysteine residues in the outer 
loop of SR-BI are crucial for doing so (Papale et al. 2011). Furthermore the N-terminal SR-
BI contains a glycine dimerization motif essential for lipid transport (Gaidukov et al. 2011). 
SR-BI also contributes to cholesterol efflux by binding cholesterol and inducing signaling 
via the c-terminal PDZ-interacting domain (Assanasen et al. 2005; Kocher & Krieger 
2009). The PDZK signaling of HDL via SR-BI has been shown as one of the key factors 
for maintenance of the endothelial monolayer (Zhu et al. 2008). 
SR-BI is functioning as a cholesterol sensor for the plasma membrane and regulates 
thereby efflux and signaling (Saddar et al. 2013).  
Eckhardt et at showed that the second isoform of SR-BI (SCARB1.2) is also binding and 
internalising HDL (Eckhardt et al. 2004). This splice variant has a dileucine motif, in which 
the C-terminus is responsible for interaction with clathrin indicating that the internalization 
is at least partially clathrin dependent (Eckhardt et al. 2006). 
In addition, HDL binding to SR-BI (probably SCARB1.1 only) stimulates the endothelial 
nitric oxide synthase (eNOS, NOS3) which leads to NO dependent relaxation of the vessel 
and release of superoxide and other radicals by NO degradation (Yuhanna et al. 2001).  
Our laboratory identified SR-BI as a modulator of HDL uptake and transport through 
endothelial cells, (Rohrer et al. 2009b). Using siRNA knockdown, SR-BI was shown to 
play this role together with ABCG1. The mechanism, by which SR-BI is facilitating HDL 
holoparticle uptake into ECs is not resolved. 
4.8.1.2 CD36	  
Originally CD36 was identified as the macrophage receptor for apoptotic cells in 
Drosophila, giving it the suitable name Croquemort (Franc et al. 1996; Franc 1999). 
 21 
As members of the same protein family CD36 and SR-BI are sharing high homology and 
architecture. Cholesteryl-ester uptake from HDL is mediated by both SR-BI and CD36 via 
binding of HDL to the extracellular domain but the C-terminal domain of SR-BI enhances 
the efficiency of cholesteryl-ester uptake 7 fold compared to CD36 (Connelly 1999). 
OxLDL, also a ligand to both SR-BI and CD36 has been shown to be differently taken up 
and transported when internalized by the one or the other receptor (Sun et al. 2007).  
4.8.1.3 ABCA1	  
ATP-binding cassette protein A1 (ABCA1) facilitates the transfer of free cholesterol and 
phospholipids to ApoA-I for the formation of HDL (Yokoyama 2005; Yokoyama 2006). It 
contains two intracellular nucleotide binding domains (NBD) which after binding of ApoA-I, 
hydrolyse ATP and thereby trigger conformational changes (Nagao et al. 2012). The c-
terminus of ApoA-I is essential for specific binding to ABCA1 (Ohnsorg et al. 2011). 
It has been shown that ABCA1 activity creates 2 types of apoA-I binding sites at the cell 
surface. Low capacity binding involves the direct apoA-I/ABCA1 interaction and exerts 
regulatory effects. The much higher capacity site generated involves apoA-I/lipid 
interactions and leads to the assembly of nascent HDL particles (Vedhachalam et al. 
2007). 
The association of apoA-I with lipids reduces its ability to interact with ABCA1 (Denis et al. 
2004). During generation of HDL, lipid free ApoA-I is lipidated and stabilizes ABCA1 to 
support this via feedback regulation. Weakly lipidated small HDL are still acceptors for 
cholesterol and lipids from ABCA1 (Favari et al. 2009). Mature, spherical HDL only under 
certain conditions or modifications HDL can be recognized by ABCA1. For example, lipid 
rich spherical HDL with lipidated apoproteins which are oxidized ex vivo by peroxidase-
generated tyrosyl radical can behave like lipid-free apoA-I to increase ABCA1 protein 
levels and activity (Hossain et al. 2012). 
The interaction of lipid free ApoA-I with ABCA1 is impaired, if ApoA-I is oxidized by 
myeloperoxidases (Shao et al. 2010; Shao 2012).  
Binding of lipid-free and lipid-poor ApoA-I to ABCA1 induces the autophosphorylation of 
the Janus kinase 2 (JAK2) which leads to the phosphorylation of signal transducer and 
activator of transcription 3 (STAT3) to translocate into the nucleus to initiate anti-apoptotic 
and anti-inflammatory signals (Liu & Tang 2012).  
The lipidation of ApoA-I by interaction with ABCA1 in macrophages generates an 
interaction partner for another ABC-transporter, namely ABCG1 (Lorenzi et al. 2008). As 
in macrophages, this cascade enhances cholesterol efflux in endothelial cells. This two 
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steps contribute to transcytosis of ApoA-I (Cavelier, Rohrer, et al. 2006; Ohnsorg et al. 
2011)  
Traditionally the interaction of ApoA-I with ABCA1 is thought to happen on the cell 
surface. However, it has been suggested that lipid efflux takes place inside vesicles 
intracellular via retro-endocytosis. According to this model, ApoA-I is taken up by cells in a 
ABCA1 and clathrin dependent manner as it is found in Rab5 endosomes and then Rab4 
dependently exocytosed again (Azuma et al. 2009).  
4.8.1.4 ABCG1	  
ABCG1 belongs to a different class of ABC transporters. In contrast to ABCA1 it is a half 
transporter that needs to (homo)dimerize to be active. Moreover it interacts with lipidated 
HDL particles rather than with lipid free ApoA-I. It functions mainly as an intracellular sterol 
transporter (Tarling & Edwards 2011; Tarling 2013). It has been found that the dimer of 
ABCG1/ABCG4 is involved in cholesterol transport to HDL (Wang et al. 2008; Cavelier, 
Lorenzi, et al. 2006) although this would contradict the more recent works of Tarling and 
Edwards. Its knockdown in ECs results in a modulation of HDL binding, cell association 
and transport (Rohrer et al. 2009b) by probably indirect means which are still to be 
resolved.  
4.8.1.5 F1-­‐ATPase	  
In hepatocytes and endothelial cells, the plasma membrane localized F1-ATPase was 
identified to bind ApoA-I (Radojkovic et al. 2009; Vantourout et al. 2010) and facilitate HDL 
endocytosis via RhoA/ROCK1 signaling (Malaval et al. 2009; Esteve et al. 2003). In 
endothelial cells it was identified to bind ApoA-I and thereby hydrolyse ATP to ADP which 
then further signals via P2Y receptors to modulate lipidated ApoA-I and HDL uptake and 
transcytosis through the endothelium (Cavelier et al. 2012).  
4.8.1.6 GPI-­‐HBP1	  
Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPI-
HBP1) was isolated by expression cloning of a murine hepatic cDNA library as a receptor 
for HDL in CHO cells (Ioka et al. 2003). Although originally identified as an HDL binding 
protein, GPI-HBP1 of capillary endothelial cells was found to bind lipoprotein lipase (LPL) 
in the subendothelial space for transcellular transports to the capillary lumen (Gin et al. 
2011; Young et al. 2011). Furthermore it is stabilizing LDL and prevents its inhibition by 
angiopoietin-like 3 and angiopoietin-like 4 (Sonnenburg et al. 2009).   
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4.8.1.7 Endothelial	  Lipase	  
Endothelial lipase (EL) hydrolyses phospholipids and thereby converts larger HDL into 
smaller HDL particles (Jahangiri et al. 2005). EL was also shown to to mediate the cellular 
binding and uptake of HDL independently of its enzymatic activity via a heparan sulfate 
proteoglycan-mediated pathway (Fuki et al. 2003). Interleukin 6 stimulates EL expression 
and thereby the transendothelial transport of HDL (Robert et al. 2013).  
4.8.1.8 Cubilin/Megalin	  
Cubilin is a modular endocytic receptor which works together with Megalin (LDL receptor 
related protein 2 – LRP2) especially in renal proximal tubules for uptake of albumin (Zhai 
et al. 2000) ApoA-I and HDL (Hammad 2000) which would otherwise be lost to the body.  
Cubilin deficiency reduces renal recovery of albumin as well as ApoA-I, decreasing their 
blood levels (Aseem et al. 2013). In addition to the reabsorbtion, the cubilin-megalin 
complex has been shown to play a crucial role as an HDL receptor during development. 
Disruption of cubilin is lethal. Mutant mouse embryos develop uncomplete somites and 
endoderm and also fail to absorb and transport maternal HDL to the embryo (Smith et al. 
2006). Further alveolar cells type 2 take up HDL via the cubilin-megalin system (Kolleck et 
al. 2002). During the development the endothelium expresses megalin but not cubilin 
(Drake et al. 2004). However it is not yet clear if the two receptors have any function in the 
mature endothelium.   
4.8.2 ApoA-I and HDL in Atherosclerosis 
Atherosclerosis is characterized by progressive accumulation of lipids in the arterial intima 
leading to plaque formation. The plaque consists not only of free cholesterol chrystals and 
agglomerated proteins such as oxidized ApoA-I (Didonato et al. 2013) but also 
macrophages which are recruited to the intima to remove the extracellular cholesterol.  
Epidemiological studies show an inverse association of HDL cholesterol with 
cardiovascular events. However the causality of this relationship is controversially 
disputed. Raising HDL concentrations by blocking cholesteryl ester transfer protein 
inhibition failed to lower the risk of cardiovascular events (Schwartz et al. 2012). It has 
hence been argued that low HDL cholesterol is only a bystander of another pro-
atherogenic condition notably hypertriglyceridemia. Alternatively, HDL cholesterol 
measurements are not sufficient to explain the anti-atherogenic properties of HDL, which 
may vary in different disease states.  
Classically HDL has been postulated to be key carrier and acceptor of cholesterol 
(Rothblat et al. 1986; Marcel et al. 2008; Hellerstein & Turner 2014). It is removing the 
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cholesterol from plaques of the intima. In addition, HDL was found to exert many anti-
inflammatory, anti-oxidative and anti-thrombotic as well as many vasoprotective activities. 
Many of these activieis are exerted in the vascular wall rather than in the plasma.  
Therefore HDL has to pass the endothelium of blood (Rohrer et al. 2009a) and lymphatic 
vessels (Lim et al. 2013; Martel et al. 2013) to get into contact with the cholesterol loaded 
macrophages in the intima and plaque.  
4.9 Need for a method to visualize 1.4 nm nanogold in HPF-FSF 
electron microscopy 
Intracellular trafficking is of major importance for both the metabolism and function of 
lipoproteins. In particular, relatively small HDL and LDL can be tracked neither by light nor 
by electron microscopy without labeling. For bright field and fluorescence microscopy, a 
variety of tracers has been established for the detection of lipoproteins within cellular 
compartments of interest. Potential impact of these tracers on the outcome is negligible 
since their size is usually below the spatial resolution of diffraction limited light 
microscopes. However, the enhanced resolution of electron microscopy (EM) and super 
resolution nanoscopy has the power to make the effects of the label visible. 
The risk of interference of biological properties by the ligand increases with its size. Bare 
colloidal gold particles are phagocytosed and pinocytosed (França et al. 2011) and are 
known to self-aggregate and thereby to appear clustered rather than as single particles. 
These interferences might become a serious issue, especially when the cellular itinerary 
of interest is little characterized or ligand-receptor interactions are weak. Colloidal gold 
was used in a variety of traditional EM studies for following a number of proteins and gave 
insight into their trafficking (Handley et al. 1981; Morris & Saelinger 1984; Kikuta & Rosen 
1994; Sawaguchi et al. 2001). The use of nanogold instead of the classical colloidal gold 
to label ligands for tracking studies (Morphew et al. 2008; Prescianotto-Baschong & 
Riezman 2002) may prevent unwanted effects. However, the small size of nanogold limits 
its direct detection by EM.  Silver (Stierhof et al. 1991; Danscher 1981) and gold (Pohl & 
Stierhof 1998) based enhancement methods were developed for the use in immuno-EM 
detection of antibodies on the surface of thin sections of embedded samples. However, 
the accessibility of nanogold for silver enhancement is limited to gold particles exposed at 
the surface of a section and leaves the nanogold within the section unaffected. Therefore, 
it is essential to enhance nanogold in the entire sample to benefit from novel three-
dimensional EM technologies such as ion beam scanning EM (FIB-SEM) or automated 
ultrathin sectioning in scanning EM (SEM). Slam freezing or high pressure freezing (HPF) 
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are state of the art techniques to stop biological processes quickly while preserving the 
ultrastructure without generating ice crystals (Kellenberger 1991; Sartori et al. 1993). 
However, nanogold enlargement with silver or gold after HPF and FSF processed and 
embedded samples using classical methods results in very low detection rates and high 
background due to self-nucleation of the enhanced material.  
Recently, two methods were developed for the enhancement of small gold particles in the 
whole volume of chemically fixed and freeze substituted samples after HPF (He et al. 
2007; Morphew et al. 2008). However, these methods require several days of incubation 
in acetone at -60 °C during freeze substitution, several washing and handling steps, as 
well as the use of water and methanol (Morphew et al. 2008).  
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4.10 Aims of this Thesis 
High density lipoproteins (HDL) and their main protein constituent, apolipoprotein A-I 
(ApoA-I), are known to be atheroprotective. According to the reverse cholesterol transport 
(RCT) model, HDL removes cholesterol from the vessel wall to the liver for recycling or 
excretion. 
However it is unclear how HDL passes the endothelium to reach and leave the intima. The 
understanding of these pathways may advance our knowledge on the pathogenesis of 
atherosclerosis and open avenues for treatment and prevention. Our lab has previously 
shown that transendothelial transport of ApoA-I and HDL is a regulated and specific 
process involving the activities of ABCA1 (Cavelier, Rohrer, et al. 2006), F1-ATPase 
(Cavelier et al. 2012), ABCG1, SR-BI (Rohrer et al. 2009b) and EL (Robert et al. 2013). 
However on the spatial level, neither the interactions of ApoA-I or HDL with these proteins 
nor the intracellular itinerary of HDL and ApoA-I have been resolved yet.  
 
To this end, my thesis addresses the following questions: 
• What is the trafficking route of HDL/ApoA-I in endothelial cells?  
• What are the subcellular localization and HDL/ApoA-I interaction sites of ABCA1, 
ABCG1, SR-BI and EL in endothelial cells? 
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5 Materials and methods 
5.1.1 Cell culture 
Primary Bovine Aortic Endothelial cells (EC) were cultured in Dulbecco’s modified eagle’s 
medium (DMEM) with 5% fetal bovine serum at 37 °C in 5% CO2 and passaged every 7-8 
days 1:1. A 10 cm cell culture treated petri dish was populated with 2.5 – 3 x 106 cells. 
Cells were pelleted for freezing by centrifugation at 200 g for 5 minutes at room 
temperature (rt). The pellets were gently resuspended in vials of 0.5 ml per 3 x 106 cells in 
the freeze mix solution consisting of the growth medium supplemented with 10% DMSO. 
Freezing of stocks to liquid nitrogen storage was performed in isopropanol containing 
nalgene boxes at -80 °C starting from room temperature (rt). Thawing of cells was 
performed by immediately heating up the cryo vial to 37 °C for 2 minutes and then 
transferring the contents gently to a new 10 cm petri dish containing 10 ml of growth 
medium, which was exchanged after the cells adhered to the surface to remove the 
DMSO.  
5.1.2 Preparation and labeling of lipoproteins 
HDL and LDL were isolated from normolipidemic human plasma (blood bank of cantonal 
hospital Schaffhausen) by sequential ultracentrifugation following the protocol described 
by Tong et al (Tong et al. 1998) and stored at 4 °C. Lipid free ApoA-I was generated by 
delipidation of HDL by ethanol-ether (Brown et al. 1969) and purification over an anion 
exchanger column (Mono-Q) on the Äkta FPLC (GE Healthcare). Qualitative purity control 
was performed by SDS-PAGE, coomassie-staining verifying the HDL and ApoA-I fractions 
to be void of visible albumin and ApoB (LDL) bands.  
Lipoproteins were labeled with 1.4 nm nanogold (Nanoprobes USA) or fluorescent Atto 
dyes obtained as succimidyl-ester (Atto-Tec, Germany) and set to pH 8.0 by 1 M NaHCO3 
to a final concentration of 0.1 M. The reaction was performed in the dark at room 
temperature for 2 hours. The labeled lipoproteins were separated from free label by gel 
filtration chromatography (Nap5 column GE). 
5.1.3 Lipoprotein uptake studies by fluorescence light (FLM) and electron microscopy 
(EM) 
For fluorescence light and electron microscopy experiments, collagen I coated transwell 
inserts (0.4 um low density, BD) or round Nr 1.0 glass coverslips (Metzler Glass / Thermo 
Fisher) of 12 mm diameter were seeded 48-96 hours before the experiments with 10’000 
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cells per 24 well insert and coverslip, respectively. To analyze the subcellular distribution, 
the labeled lipoproteins were added to the cells for 30 minutes at 37 °C in 5% CO2 if not 
otherwise indicated followed by rinsing with ice cold PBS++ (PBS 7.4 with 1 mM CaCl2 
and 0.1 mM MgCl2). For binding experiments, the cells were incubated at 4 °C in a 
humidified closed box. Subsequently, cells were either chemically fixed for fluorescence 
microscopy or high pressure freezing (HPF) for EM analysis. 
 
 
Epitope Antibody  Dillution Company 
58kDa Golgi 
Protein 
m-58kGolgi ab27043 
58k-9 
1:400 Abcam 
ABCA1 
m-ABCA1 ab18180 
AB.H10  
1:50 Abcam 
ABCG1 
Rab-ABCG1 sc20795 
H65 
1:200 Santa Cruz 
Actin betaActin AC15 1:500 Sigma 
Calnexin Rab-calnexin Sigma 1:400 Sigma 
Caveolin 1 Rab-Cav1 ab2910 1:250 Abcam 
CDC42 m-CDC42 ab41429 1:600 Abcam 
Clathrin m-Clathrin ab2731 X22 1:400 Abcam 
F1F0 alpha 
ATPase 
m-F1F0alpha MS502 1:800 Mitosciences 
LIPG (endothelial 
lipase) 
Rab-EL nb400-111 A4 
1:200, 
probably 
offtarget 
binding 
Novus 
LIPG (endothelial 
lipase) 
Rab-LIPG HPA016966 1:500 
Sigma-Aldrich 
(Human Protein 
Atlas) 
Rab11a Rab-rab11a ab65200 1:500 Abcam 
Rab5 Rab-rab5 ab13253 1:400 Abcam 
Rab7 Abcam XP anti Rab7 1:800 Abcam 
Rab9 m-rab9 ab2810 Mab9 1:800 Abcam 
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Table 3: Immunostaining Antibodies used 
5.1.4 Fixation for FLM 
Chemical fixation for FLM was performed with 3.75% formaldehyde in PBS at room 
temperature (rt) for 20-30 minutes for monolayers of cells and one hour for 7 – 18 μm 
thick cryosections of tissues. The free fixative was then quenched by a brief wash with 0.5 
M TrisHCL 8.0 followed by two washes with PBS. Then either additional stainings were 
performed or the sample was embedded directly for microscopy.  
5.1.5 Indirect Immunostainings for FLM 
Coverslips or transwell inserts with fixed cells were preincubated with 0.1 % saponin in 
PBS at pH 7.4 at rt for 15 minutes if permeabilisation was needed for antibody staining. 
The primary antibody was incubated for one hour at rt or 16 h at 4 °C, the cells were then 
washed tree times with PBS and then incubated with the secondary antibody for 30 – 45 
minutes at rt in the dark. Antibody dilutions were made always in PBS with 1 % Donkey 
Serum (Sigma Aldrich) and 5 % BSA. Concentrations were determined beforehand using 
an antibody by trying 1:200 – 1:10000 dilutions.  
5.1.6 Preparation for FLM and image acquisition 
After all desired stainings had been done, the coverslips were directly mounted upside 
down on glass slides with ProLong Gold antifade solution (Life technologies, USA). 
Transwells were cut out with a scalpel Nr11 from the bottom side and placed with the cells 
upwards between a glass slide and a 25x50 mm Nr 1.0 coverslip (Metzler Glass / Thermo 
Fisher) with a drop of ProLong Gold inbetween. 
Images were acquired with a Hamamatsu ORCA-ER EMCCD camera (C4742) at full 
resolution and fixed exposure time of 10 to 800 ms to have the signal histogram of the 
SR-BI 
Rab-srb1 ab3, 
discontinued 
1:500 Abcam 
SR-BI Rab-srb1 ab24603 1:200 Abcam 
SR-BI 
Rab-srb1 nb400-104 H6 
or M3 
1:400 Novus 
Syntaxin 6 Abcam XP anti Stx6 1:800 Abcam 
TJP1 Rab-TJP1 HPA001636 1:400 
Sigma-Aldrich 
(Human Protein 
Atlas) 
ZO1 m-ZO1 33-9100 1:500 Novex 
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(positive) control in the middle of the 12 bit sensitivity range of the chip and this exposure 
was kept throughout the acquisition session.  
5.1.7 High pressure freezing (HPF) and freeze substitution fixation (FSF) for EM 
The membrane of the transwell containing a monolayer of endothelial cells was punched 
out with a biopsy-punch of 5 mm diameter. The isolated membrane was carefully inserted 
into a 6 mm aluminium specimen carrier with an indentation of 100 µm, sandwiched with a 
flat carrier wetted with 1-hexadecene (Sigma Aldrich, CH) and immediately high pressure 
frozen using an automated Leica EM HPM100 high pressure freezing machine (Leica 
Microsystems, Vienna, Austria). Samples were stored in liquid nitrogen until further 
processing. 
HPF frozen discs containing membranes with cell monolayers were transferred to 2 ml 
safe-lock Eppendorf tubes containing 1% OsO4 at -90 °C.  Substitution was performed in 
an automated substitution machine (Leica EM AFS) at -90 °C for 7 h, -60°C for 6 h, -30°C 
for 5 h and at 0 °C for 1 h with transition gradients of 30°C per hour. 
5.1.8 Silver enhancement  
The reagents (Sigma Aldrich, CH) were prepared in individual tubes as saturated solutions 
of hydroquinone, malic acid, and silver nitrate in anhydrous acetone at room temperature. 
Arabic gum was dispersed in anhydrous acetone and shaken for one hour at room 
temperature. The Arabic gum dispersion was used to protect the colloid by inhibiting the 
self-nucleation of silver.  
After slowly cooling the saturated solutions to 0°C during one hour, equal parts of all 
saturated solutions and the Arabic gum suspension were mixed at 0 °C. The mixture was 
centrifuged at 300 g for 5 min at 4 °C to remove any precipitates and was always freshly 
prepared before use. 
After FSF the samples were washed three times with anhydrous acetone and the 
enhancement mixture was added to the reaction tubes for 30 minutes. Afterwards, the 
treated samples were washed again three times with anhydrous acetone before 
embedding in epoxy resin. All steps were performed at 0 °C on ice water. The classical 
on-section silver enhancement of gold particles was performed with freshly made 
solutions after Danscher et al. (Danscher 1981) or alternatively Aurion Gold SE-EM 
(Aurion, NL) as described by the supplier. 
5.1.9 Embedding and preparation for TEM and EM image acquisition 
Samples in anhydrous acetone were embedded in Epon/Araldite (EA) essentially as 
described by Hohenberg et al. (Luft 1961; Hohenberg et al. 1994) by incubating the 
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samples in  33 % and 66% EA in acetone for 8 h each prior to transfer in 100 % EA and 
polymerization at 60 °C for 40 hours. 
Ultrathin cross sections of cells of 50 nm were cut with a 45 ° diamond knife (Diatome) 
using an ultramicrotome (Reichert) and put on Formvar coated single slot grids (Ted Pella 
inc. USA).  
Images were acquired with a Philips CM100 or a FEI Tecnai G2 Spirit (FEI, Eindhoven, 
The Netherlands) at an acceleration voltage of 80 kV or 120 kV with a Gatan Orius 1000 
camera (Gatan Inc. USA). 
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6 Results 
6.1 Trafficking route of HDL/ApoA-I in endothelial cells 
To get insight into the itinerary of HDL and ApoA-I in endothelial cells, we labeled them 
with Atto488, Atto594 or Atto655 fluorescent dyes for fluorescence microscopy (FLM) and 
with 1.4 nm nanogold complexes for electron microscopy (EM).  
6.1.1 ApoA-I and HDL are binding to endothelial cells  
Fl-ApoA-I and fl-HDL were added to monolayers of ECs on coverslips and incubated at 4 
°C, briefly washed and fixed with formaldehyde before mounting. Both apoA-I and HDL 
were bound by ECs (figures 1A and 1C). Of note, the binding pattern of fl-HDL (Figure 1 
A) shows a more evenly diffused pattern than fl-ApoA-I (Figure 1 C). Moreover, fiber-like 
structures are detectable in the presence of fl-ApoA-I (Figure 1 C) but not fl-HDL (figure 
1A). Fl-HDL binding to ECs was extensively competed by a 100 fold excess of un-labelled 
HDL (Figure 1 B). By contrast binding of fl-ApoA-I was only little competed by excess of 
HDL (Figure 1 D).  
 
Figure 1: Binding of labeled HDL and ApoA-I competed with 100 x excess of not labeled HDL 
A monolayer of ECs was pre-cooled for 30 min at 4°C following by a further 30 min incubation with 50 
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µg/ml 655-HDL (A) or 50 µg/ml 488-ApoA-I (C) in the absence (A, C) or presence of 5 mg/ml HDL (B, D). 
The monolayers were then fixed with 3.75 % formaldehyde for 40 min starting at 4 °C with gradual 
heat-up to room temperature. Cover slips were also incubated with DAPI for nuclear staining and 
investigated at fixed exposure.  
 
To test for background effects and signal coming from free Atto-Dyes, we incubated ECs 
with free Atto655-Dye along with Atto655-HDL for 30 minutes. The free dye associates 
predominantly with nuclear and partially with cytoskeletal elements (Figure 2). This differs 
from the localization of fl-ApoA-I and fl-HDL indicating that the label attached to ApoA-I 
and HDL follow that of the particle and do not traffic as free label.  
 
Figure 2: Comparison of fluorescence staining of endothelial cells by fl-HDL (A) free fluorescence dye 
(B) 
A monolayer of ECs was incubated for 30 min at 37° with 50 µg/ml 655-HDL (A) or 18 μg/ml free Atto-
655 dye (B), fixed with 3.75 % formaldehyde and counter-stained with DAPI (A only) for nuclear 
staining. Note the different staining pattern of Atto-655 and 655-HDL. 
 
6.1.2 Uptake of ApoA-I and HDL 
Fl-HDL was added to monolayers of EC on coverslips and incubated at 37 °C for different 
timepoints after which the cells were briefly washed and fixed with PFA before mounting.  
HDL can be detected after about 5 minutes and the signal increases with the prolongation 
of incubation. At different timepoints, HDL is recovered in different compartments of the 
cells. The intracellular distribution of HDL after one hour is clearly different from the earlier 
shorter timepoints (Figure 3 A through D).  
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Figure 3: Time-dependent uptake of fl-HDL by EC monolayers. A monolayer of ECs was incubated for 
(A) 5 min, (B) 15 min, (C) 30 min and (D) 60 min at 37° with 50 µg/ml 594-HDL, fixed with 3.75 % 
formaldehyde and counter-stained with DAPI for nuclear staining. The longer fl-HDL is incubated with 
ECs, the more can be detected intracellular.  
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When HDL and ApoA-I were incubated together with ECs for 30 minutes, they were found 
to colocalize perfectly, indicating a shared route of trafficking (Figure 4). Therefore all 
subsequent experiments were performed on HDL. 
  
 
Figure 4: ApoA-I co-localizes perfectly with HDL inside ECs 
A monolayer of ECs was incubated for 30 min at 37° with 50 μg/ml of each 488-ApoA-I and 594-HDL, 
fixed with 3.75 % formaldehyde and counter-stained with DAPI for nuclear staining. In A, the 488-
ApoA-I signal is visualized, in B the one of 594-HDL. In C, the merge of A and B shows uniform co-
localization of ApoA-I and HDL.  
 
6.1.3 Co-localization of ApoA-I and HDL with markers of endocytosis 
There are clathrin and caveolin dependent processes of endocytosis as well as endocytic 
pathways independent of clathrin and caveolin. We incubated fl-HDL for 30 minutes with 
ECs and subsequently stained the cells for clathrin or caveolin 1. Neither showed any 
colocalization with HDL (Figure 5 A and B). Since we saw almost no vesicles at very short 
time points, we reduced the temperature during the incubation with HDL and repeated the 
co-localization experiments. Also at 18 °C no co-localization of these endocytotic markers 
with HDL was seen (Figure 5 C and D).  
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Figure 5: HDL colocalizes with neither clathrin nor cav1 at 37 °C or 18 °C  
Monolayers of ECs were incubated for 30 min at 37° (A and B) or 18 °C (C and D) with 50 µg/ml fl-HDL, 
fixed with 3.75 % formaldehyde and stained with anti-Clathrin (A and C) or anti-Cav1 (B and D) in the 
corresponding secondary antibody (A and B – Alexa-594; C and D – Alexa 488) counter-stained with 
DAPI for nuclear staining. At neither 37 °C nor 18 °C HDL was found colocalized with clathrin or 
caveolin 1.  
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Since Transferrin (Trf) is taken up by ECs via the Transferrin receptor (TrfR) in both a 
clathrin dependent and independent manner (Roberts & Sandra 1994; Roberts et al. 1993; 
Tsuji et al. 2013; Kishimoto & Tavassoli 1987; Fishman et al. 1987) to supply of 
themselves well as the tissues below the endothelium with iron, we tested for a 
convergence between the pathways of HDL and Trf in ECs. When FL-HDL and 
fluorescently labeled Trf were added to ECs with 1-2 minutes difference and incubated for 
30 minutes, partial overlap with the two fluorescence signals was detected indicating 
crossroads in the vesicular transport of HDL and Trf in ECs (Figure 6).  
 
 
Figure 6: partial co-localization of HDL with Transferrin 
A monolayer of ECs was incubated for 30 min at 37° with 50 µg/ml FITC-HDL and 5 µg/ml 594-Trf, fixed 
with 3.75 % formaldehyde and counter-stained with DAPI for nuclear staining. In A, the FITC-HDL 
signal is visualized, in B the one of 594-Transferrin. In C a merge from A and B is showing partial the 
co-localization between HDL and Transferrin. 
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Albumin is transcytosed through the ECs via caveolae and dependent of both caveolin 1 
and the gp60 receptor (Vogel et al. 2001; Geoffroy & Becker 1984). We compared its 
itinerary with the one of HDL. When incubated for 30 minutes, fl-albumin was partially 
colocalized with fl-HDL (Figure 7).  
 
Figure 7: HDL partially co-localizes with Bovine Serum Albumin (BSA) 
A monolayer of ECs was incubated for 30 min at 37° with 50 µg/ml FITC-HDL and 10 μg/ml 546-
Albumin, fixed with 3.75 % formaldehyde and counter-stained with DAPI for nuclear staining. In A, the 
FITC-HDL signal is visualized, in B the one of 546-BSA. In C a merge from A and B is showing the 
partial co-localization between HDL and Transferrin. 
 
To test for HDL uptake by fluid phase, we treated ECs with Amiloride and EIPA, two 
inhibitors for Na/H channels needed for fluid phase trafficking. In either condition Fl-HDL 
up take was almost normal indicating that HDL uptake is not driven by fluid phase (Figure 
8 A-C). To corroborate this finding, ECs were coincubated with fl-HDL together with 
fluorescently labeled 40 kDa Dextran, a marker for fluid phase uptake. There was no co-
localization visible (Figure 8 D-F).  
 39 
  
 
Figure 8: HDL uptake cannot be blocked by Amiloride or EIPA and it does not colocalize with 40 kDa 
Dextran 
A-C: A monolayer of ECs was preincubated for 30 min with either 10 µM Amiloride or 2 µM EIPA 
before 50 µg/ml 655-HDL was added and incubated for another 30 min, fixed with 3.75 % formaldehyde 
and counter-stained with DAPI for nuclear staining.  
D-F: A monolayer of ECs was incubated with 50 µgml 655-rHDL together with FITC-40kDa Dextran for 
30 min, fixed with 3.75 % formaldehyde and counter-stained with DAPI for nuclear staining 
 
To test for the involvement of the lipid kinases of the PI3/4K family, which were recently 
identified to play a role in clathrin independent endocytosis (Basquin & Sauvonnet 2013), 
we used pharmacological inhibition by wortmannin, a general inhibitor for PI3/4K kinases. 
Pretreatment of ECs with 2 μM wortmannin for 20 minutes resulted in reduced HDL 
uptake and changed its vesicular distribution. The HDL containing vesicles were blown up 
(Figure 9 A vs B).  
When dynamin was blocked by incubation of cells with 80 μM dynasore for 20 minutes at 
37°C, ECs took up less fl-HDL. Even more strikingly, HDL positive vesicles were no longer 
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localized on one side of the nucleus but randomly distributed around the nucleus. In the 
presence of dynasore at 18 °C which decreases membrane fluidity as well as the  fission 
and fusion of vesicles, fl-HDL appeared as a patchy pattern over the whole monolayer of 
ECs in (Figure 9).  
 
 
Figure 9: HDL uptake is altered by Wortmannin and Dynasore 
A monolayer of ECs was preincubated at 37 °C (panel A-C) or 18 °C (panel D-F) for 30 min with either 
0.2 mM Wortmannin (B and E) or 80 µM Dynasore (C and F).  
50 µg/ml 596-HDL was added (A-F) and incubated for another 30 min, fixed with 3.75 % formaldehyde 
and counter-stained with DAPI for nuclear staining.  
 
To follow the cell surface protein steady state internalization and highlight the whole 
endocytotic pathway of ECs, we labelled all N-acetyl-glucosamine (GlycNAc) residues on 
the cell surface of ECs with the fluorescently labeled lectin wheat-germ agglutinin (fl-
WGA).  
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After adding fl-HDL to the fl-WGA treated cells, complete co-localization was observed in 
the first 10 minutes which weakened during the subsequent 20 minutes and disappeared 
after one hour (Figure 10).  
 
 
Figure 10: HDL colocalizes with WGA in 10-30 min but not after that time 
A monolayer of ECs was incubated with 1 µM 594-WGA for 20 min and 50 µg/ml 488-HDL for 15 min 
(A), 30 min (B) and 60 min (C), cells were fixed then with 3.75 % formaldehyde and counter stained 
with DAPI for nuclear staining. 
Endothelial cells also take up acetylated LDL (AcLDL) via scavenger receptors. To test 
whether HDL shares this pathway, we incubated fl-AcLDL and fl-HDL with ECs and found 
almost no colocalisation inside the cells (Figure 11).  
 
 
Figure 11: AcLDL does not colocalize with HDL 
A monolayer of ECs was incubated for 30 min at 37° with 50 µg/ml 655-HDL and 20 µg/ml 488-AcLDL, 
fixed with 3.75 % formaldehyde and counter-stained with DAPI for nuclear staining. In A, the 655-HDL 
signal is visualized, in B the one of 488-AcLDL. In C a merge from A and B is showing almost no co-
localization between HDL and AcLDL. 
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6.1.4 HDL is trafficking through different compartments over a period of 4 hours 
During incubations for different time intervals ranging from 5 minutes to 16 hours, the 
cellular localization of HDL changes significantly. At early time points HDL was hardly 
detectable. We observed that preincubation of ECs with unlabeled HDL enhanced the 
binding of HDL (see Figure 26). We exploited this phenomenon for visualizing the binding 
of HDL. After stimulation of ECs with 50 µg/ml HDL for 30 minutes and subsequent 
incubation of ECs with fl-HDL, this fl-HDL can be visualized in small-punctuated patterns. 
After prolonged incubations for up to 120 minutes HDL was reshuffled into bigger vesicles 
at the same location (Figure 12 E and F). After 2-3 hours, the HDL is further moved to 
another compartment, and after 16 h we observed HDL in bigger vesicles (Figure 12 G-I).  
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Figure 12: HDL uptake over 5 minutes up to 16 hours.  ECs were pre-stimulated with HDL to increase 
HDL uptake . A monolayer of ECs was incubated for 5 min (A), 10 min (B), 15 min (C), 30 min (D), 60 
min (E), 120 min (F), 180 min (G), 240 min (H) and 16 h (I) as indicated with 50 µg/ml 596-HDL, fixed 
with 3.75 % formaldehyde and counter-stained with DAPI for nuclear staining. 
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6.1.5 HDL is passing the endothelial monolayer faster than it accumulates inside the 
vesicles identified 
To visualize the internalization of HDL at real time, Fl-HDL was added to ECs while 
scanning at maximum speed on a confocal microscope the xyz volume of a EC and it’s 
surrounding. After two minutes already some fl-HDL was passing through the monolayer 
and retrieved in the subendothelial space. After only 15 minutes it could be observed in 
internal vesicles (Figure 13). 
 
 
Figure 13: HDL passes through the EC monolayer in less than 2 minutes, much before any vesicles 
can be detected intracellularly 
Monolayers of ECs were grown on transwell inserts which were then put on a drop of medium on a 
petri dish with optical glass bottom and scanned from below at a inverse confocal microscope. After 
the first volume scan, the 488-HDL was given into  the transwell and scanning was continued. A 
shows the first scan, B the 20th scan after 15 minutes of adding 488-HDL to the cell layer 
 
 
6.1.6 Colocalization of HDL with organelles 
LDL is taken up by all cells via the LDL receptor or related gene family members(e.g. 
LRP). The majority is targeted to the lysosomes for satisfying the cellular need of 
cholesterol and free fatty acids. Only a small proportion is transcytosed through ECs as 
intact particles (Nistor & Simionescu 1986). To test if HDL is also transported to 
lysosomes for degradation and cholesterol uptake, we used Lysotracker DND 99 (Life 
Technology), a pH dependent red fluorescent dye to visualize lysosomes and late 
endosomes in cells, which we incubated with green labeled HDL. As shown in Figure 14, 
there is very little if at all co-localization of lysotracker signals with HDL indicating that, at 
the timepoints investigated, HDL is not transported to lysosomes (Figure 14). 
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Figure 14: HDL does not colocalize with Lysotracker DND 99 
A monolayer of ECs was incubated for 30 min at 37° with 50 µg/ml FITC-HDL and during the last 10 
min additionally with 1 µM Lysotracker DND, fixed with 3.75 % formaldehyde and counter-stained with 
DAPI for nuclear staining.  
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There is a distinct caveolar endocytotic pathway known to target the golgi or 
endoplasmatic reticulum (ER) (Le 2003). HDL positive vesicles were found accumulating 
around one side of the nucleus so that we speculated that HDL is transported into the 
golgi or ER. We added fl-HDL for 30 minutes to ECs. After fixing the cells and labellig the 
ER with anti-Calnexin antibodies (Figure 15 A,B,C) and the golgi with anti-golgi58-protein 
(Figure 15 D,E,F) neither organelles were colocalized with HDL but the HDL positive 
vesicles were in close proximity to the Golgi.  
 
 
Figure 15: HDL fails to co-localize with Golgi or ER but clusters around the golgi positive vesicles 
Monolayers of ECs were incubated for 30 min at 37° with 50 µg/ml fl-HDL, fixed with 3.75 % 
formaldehyde and stained with anti-Calnexin (B) or anti-Golgi58kProtein (E) and the corresponding 
secondary antibodies labeled with Alexa-488. DAPI was used for nuclear staining. HDL was 
colocalized with neither the ER (merge in C) nor the Golgi (merge in F).  
 
As we observed HDL uptake by ECs, we tested colocalization of HDL with early or late 
endosomes (Rab5 or Rab7), recycling endosomes (Rab11a), and endosome-trans golgi 
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network trafficking (Rab9 and Syntaxin6). ECs were incubated with fl-HDL for 30 minutes 
and after fixing, the cells were stained against the proteins described above. Unfortunately 
none of the vesicle markers we used appeared to co-localize with HDL indicating that HDL 
passes quickly through endosomes if at all to end up in other vesicles that are Rab5 
and/or Rab7 negative (Figure 16). Negative co-localization with Rab 11a (Figure 17) and 
Syntaxin 6 and Rab9 (Figure 18) indicate neither back transport to the plasma membrane 
nor transport to the trans golgi network. 
 
 
Figure 16: HDL does not colocalize with early (Rab5) and late (Rab7) endosomes 
Monolayers of ECs were incubated for 30 min at 37° with 50 µg/ml fl-HDL, fixed with 3.75 % 
formaldehyde and stained with anti-Rab5 (B) or anti-Rab7 (E). The secondary antibodies were labeled 
with Alexa-488. DAPI was used for nuclear staining. Neither the early endosomes (Rab5 – merge in C) 
nor late endosomes (Rab7 – merge in F) colocalize with fl-HDL  
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Figure 17: HDL is not recycled in a Rab11a dependent manner 
Monolayers of ECs were incubated for 30 min at 37° with 50 µg/ml fl-HDL, fixed with 3.75 % 
formaldehyde and stained with anti-Rab11a (B) and a secondary antibody labeled with Alexa-488. 
DAPI wa sused for nuclear staining. The recycling endosomes (Rab11a) do not co-localize with fl-HDL 
(merge in panel C).  
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Figure 18: HDL does not colocalize with Rab9 or Syntaxin 6 
Monolayers of ECs were incubated for 30 min at 37° with 50 µg/ml fl-HDL, fixed with 3.75 % 
formaldehyde and stained with anti-Rab9 (B) or anti-Syntaxin6 (E). The corresponding secondary 
antibodies were labeled with Alexa-488. DAPI was used for nuclear staining. Neither Rab9 nor 
Syntaxin 6 colocalize with HDL (merges in C and F).  
  
50 
6.1.7 Role of the cytoskeleton on HDL trafficking 
Cytoskeleton disruption with colchicine and cytochalasin D in ECs resulted in reduced 
HDL uptake. After tubulin disruption by colchicine, HDL remained in small intracellular 
peripheral vesicles (Figure 19).  
 
 
Figure 19: HDL uptake and trafficking is affected by blocking tubulin and F-actin 
A monolayer of ECs was preincubated for 30 min with either (B) 5 µM Cytochalasin D or (C) 1µM 
Colchicine before 50 μg/ml 596-HDL was added and incubated for another 30 min, fixed with 3.75 % 
formaldehyde and counter-stained with DAPI for nuclear staining.  
 
 
 
 
6.2 Volume enhancement of 1.4 nm Nanogold-HDL for visualization in 
EM 
Since all approaches to colocalize HDL with some known structures of the cells failed, we 
investigated th elocalization of HDL by EM. As glutaraldehyde fixations are slow and a 
lipid containing particle may not be fixed fast enough to represent the real state and 
localization of HDL, we used state of the art high pressure freezing (HPF) and freeze 
substitution fixation (FSF) for sample preparation. To avoid artefacts by too big or non-
covalently bound electron microscope compatible label, we used 1.4 nm nanogold to label 
HDL. As nanogold is too small to be detected directly in EM, it had to be enhanced. 
Unfortunately classical enhancement methods were not sensitive enough to detect HPF-
FSF nanogold, so we developed our own volume silver enhancement after FSF to detect 
nanogold HDL.  
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6.2.1 Increased detection sensitivity of volume silver enhancement of 1.4 nm nanogold 
HDL after HPF and FSF compared to classical on-section silver enhancement  
To study HDL trafficking in endothelial cells, we labeled HDL with 1.4 nm nanogold and 
added it to a monolayer of EC followed by HPF for preservation for electron microscopy. 
On the one hand we performed the on-section silver enhancement of nanogold providing 
very low signal intensity (Figure 20 A and 1B), on the other hand, the volume silver 
enhancement after HPF and FSF in solution (Figure 20 C and 1D).  
As expected, much more nanogold was accessible for the enhancement reaction using 
the volume enhancement protocol. Significantly more events were detected than with on-
section enhancement (Figure 20 C and 1D compared to 26 A and 1B). On-section 
enhancement mainly provided single events on multi vesicular bodies. In contrast, using 
the volume enhancement protocol we were able to find many events, covering also other 
types of vesicles and also being more consistently appearing throughout the section. In 
addition, these pictures resembled more closely to the data obtained by fluorescence 
microscopy, which under similar conditions yielded more than just one or two vesicles 
visible in a virtual section through the cell.  
Importantly, the volume silver enhancement showed less background (electron dense 
areas) derived from the enhancement and resulted in more clearly visible ultrastructure.  
 
Figure 20: Endothelial cells were incubated for one hour with 1.4 nm Au-HDL at 37 °C, washed, then 
high pressure frozen, fixed during freeze substitution with OsO4. A and B, samples were processed 
for TEM and silver enhancement was performed on ultrathin sections. In C and D volume silver 
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enhancement was performed directly after freeze substitution. Dashes in low magnification (A and C) 
help visualize the distribution of the particles. Bar = 500 nm 
 
6.2.2 1.4 nm nanogold LDL and 1.4 nm nanogold Albumin 
To verify that our method generated results comparable to other classical methods, we 
also visualized LDL (Anderson et al. 1976; Brown & Goldstein 1979) and albumin (Vogel 
et al. 2001; Geoffroy & Becker 1984) which are known to be endocytosed by the LDL-
receptor and the GP60 cell surface protein, respectively, into endothelial cells. Both 
ligands were also coupled to 1.4 nm nanogold as the tracer and tested using the volume 
silver enhancement protocol. Both ligands were detected in endothelial cells after 30 
minutes. Au-BSA was detected to a higher extend on the surface of EC (Figure 21 A and 
27 B) compared to Au-LDL (Figure 21 C and 27 D) or Au-HDL (Figure 20 C and D).  
 
Figure 21: Endothelial cells were incubated for one hour with 1.4 nm Au-BSA (A and B) and 1.4 nm Au-
LDL (C and D), at 37 °C, washed, high pressure frozen, fixed during freeze substitution with OsO4 and 
volume silver enhancement was performed as described. Dashes help visualize the distribution of the 
particles. Bar = 200 nm 
6.2.3 High background on badly frozen samples, very low on well-frozen samples 
To verify the specificity of the volume silver enhancement and to determine the 
background generated by the improved method, the enhancement on HPF, FSF treated 
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cells was performed with native (not labeled) HDL. In Figure 22A and B hardly any silver is 
visible.  
Sometimes HPF generated badly frozen monolayers of cells on which the volume 
enhancement resulted in silver particles evenly distributed throughout the biological 
material (Figure 22 C and D). Such samples cannot be used for analysis but were easily 
detectable because of the even distribution and the ice damaged ultrastructures (Figure 
22 D).  
 
 
Figure 22: Determination of specificity and background: To determine the specificity and background 
of the volume enhancement protocol, endothelial cells were HPF/FSF after incubation with native 
(without 1.4-Au label) HDL and then volume enhanced. It shows very low background and auto-
nucleation on HPF samples with good ultrastructure conservation (A and B).  
Possible pitfalls:  HPF/FSF processed endothelial cells after incubation with 1.4 nm Au-HDL on 
transwell membranes were volume enhanced. Uniform distribution of silver particles was seen on 
sections, where the HPF freezing was suboptimal and a lot of ice damage happened (C and D). 
Bar 500 nm 
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6.3 Cellular localization of ABCA1, ABCG1, SR-BI and EL in 
endothelial cells and in bovine endothelium 
To analyse the cellular distribution of ABCA1, ABCG1, SR-BI and EL, which were 
previously found by our lab to be involved in the binding and transport of ApoA-I or HDL, 
we performed indirect immunofluorescence stainings with commercially available 
antibodies to localize ABCA1, ABCG1, SR-BI and EL in cell culture grown EC monolayers 
(Figure 23) and cryocuts of bovine aorta tissue. The tissue was cryocut and 
immunostained to detect the candidates in native endothelia (Figure 24).  
ABCA1, ABCG1 and SR-BI were found mostly intracellularly within intracellular vesicles 
rather than on the surface. Only ABCA1 and SR-BI were found at very low intensities at 
the surface (Figure 23 A and C). EL, although active extracellularly, was only 
immunodetected in vesicles (Figure 23 D). 
It turned out to be difficult to prepare cryocuts of aorta with intact endothelium. It was very 
fragile and easily displaced from the intima and eventually lost. Vasa vasorum were much 
easier to immunostain and analyse (Figure 24).  
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Figure 23: Immunostaining of ABCA1, ABCG1, SR-BI, and EL in ECs 
Monolayers of ECs were fixed with 3.75 % Formaldehyde, blocked with 5 % Donkey serum and 
incubated with the antibodies against ABCA1, ABCG1, SR-BI or EL (LIPG) and then with secondary 
alexa-coupled antibodies. In D, monolayers were incubated for 30 min with 50 µg/ml 488-HDL prior to 
fixation for co-localization studies. After indirect immunostaining, a DAPI staining was performed for 
nuclear localization. 
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Figure 24: Immunostaining for ABCA1, ABCG1, SR-BI and EL in the endothelium of aortic vasa 
vasorum (A and B) and aorta (C and D) 
Bovine aortas were obtained freshly from the slaughter house. Cubes of 5 x 5 mm including the 
endothelium were frozen in OCT upon which they were cryocut at 7-14 um thickness. The cuts were 
thawn and fixed with 3.75 % formaldehyde and then indirectly immunostained  
 
6.4 Modulation of trafficking of HDL/ApoA-I by SR-BI and HDL itself 
In biochemical studies binding of 125I-HDL to ECs was clearly seen reduced after 
knockdowns of SR-BI and EL (Rohrer et al. 2009b). However, we failed to co-localize HDL 
with ABCA1, ABCG1, SR-BI, or EL in ECs. The interaction however could be too brief with 
too few contacts for immunocolocalization.  
To analyse if inhibition of SR-BI interferes with the endothelial uptake of HDL, we 
incubated ECs with an anti-SR-BI antibody. After 30 minutes pre-incubation with the 
antibody, fl-HDL was added to the ECs and another 30 minutes later cells were fixed and 
visualy inspected. ECs preincubated with anti-SR-B antibody revealed reduced HDL 
uptake (Figure 25 A and B).  
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Alternatively the cells were pretreated with BLT1, a lipid transport inhibitor for SR-BI, for 
30 minutes to be then incubated with fl-HDL for additional 30 minutes. This BLT1 
treatment led to even more pronounced reduction in HDL uptake (Figure 25 C and D). 
 
 
Figure 25: preincubation with antiSR-BI or BLT1 reduce HDL uptake  
Monolayers of ECs were preincubated with either a blocking antibody (B) or isotype control (A) or 
BLT1 (D) at 10 µM for 20 minutes. Then 50 µg/ml 594-HDL was added to the cells and further 
incubated for 30 min (A-D), the cells were fixed with 3.75 % formaldehyde, counter stained with DAPI.  
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When ECs were incubated with unlabeled HDL for 30 minutes before incubation with fl-
HDL, the uptake of fl-HDL was enhanced (Figure 26). 
 
 
Figure 26: HDL preincubation increases uptake of HDL 
Monolayers of ECs were incubated with 100 µg/ml unlabeled HDL (B) prior to 30 minutes incubation 
with 50 µg/ml fl-HDL (A and B). The cells were fixed with 3.75 % formaldehyde and counter stained 
with DAPI for nuclear staining.  
 
6.4.1 Phosphoprotein-Profiles in ECs after exposure to HDL or ApoA-I 
We investigated HDL induced signaling in ECs by analyzing the phosphoprotein-profile 
with the phospho-kinase membrane arrays from R&D systems covering 43 kinases and 
two signaling proteins. After 30 minutes incubation of ECs with 3 different HDL 
preparations, we identified 9 consistently up-regulated and 6 consistently down-regulated 
phosphosites (Figure 27). In addition there were 10 sites, which were discrepantly 
regulated upon exposure to the different HDLs. Phosphosites downregulated by HDLs are 
WNK1 T60, HCK Y411 FAK Y397 PRAS40 T246, STAT3 Y705 and HSP27 S78/82. 
Phosphosites upregulated by HDLs include PLC-γ1 Y783, Akt T308, STAT2 Y689, p38a 
T180Y182, STAT6 Y641, eNOS S1177, p53 S46, STAT5b Y699 and c-Jun S63.   
For comparison we also investigated ApoA-I induced signaling in ECs by analyzing the 
same phosphoprotein-profile with the phospho-kinase membrane. After 30 minutes 
incubation of ECs with delipidated ApoA-I preparations, we identified 5 consistently up-
regulated and 6 consistently down-regulated phosphosites. 
Phosphosites downregulated by ApoA-I are Stat3 S727, p53 S392, HSP60, WNK1 T60, 
PLCg1 Y783 and HSP27 S78/S82. Phosphosites upregulated by ApoA-I are akt T308, c-
Jun S63, p70 s6k T421/S424, PDGF Rb Y751 and p38a T180/Y182. 
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Figure 27: Changes in the degree of phosphorylation of kinases and signaling proteins in response to 
30 min incubation of ECs with HDL. Data are means  + standard deviations of three independent 
experiments 
 
 
Figure 28 : Changes in the degree of phosphorylation of kinases and signaling proteins in response 
to 30 min incubation of ECs with 100 μg/ml lipid free apoA-I. Data are means  + standard deviations of 
three independent experiments 
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Phosphosites HDL-induced changes in 
phosphorylation (fold) 
ApoA-I induced changes 
in phosphorylation (fold) 
WNK1 – T60 0.749 + 0.170 0.869 + 0.066 
FAK – Y397 0.774 + 0.131 n.s. 
HSP27 – S78S82 0.814 + 0.101 0.925 + 0.027 
STAT3 – Y705 0.819 + 0.177 n.s. 
HCK – Y411 0.833 + 0.088 n.s. 
PRAS40 – T246 0.847 + 0.051 n.s. 
STAT3 – S727 n.s. 0.285 + 0.123 
P53 – S392 n.s. 0.749 + 0.222 
HSP60 n.s. 0.813 + 0.112 
   
PDGF Rb – Y751 n.s. 1.177 + 0.066 
P70 s6k – T421 / S424 n.s. 1.179 + 0.048 
c-Jun - S63 1.133 + 0.086 1.274 + 0.043 
STAT6 - Y641 1.132 + 0.078 n.s. 
STAT2 - Y689 1.139 + 0.042 n.s. 
STAT5b - Y699 1.141 + 0.064 n.s. 
eNOS - S1177 1.148 + 0.119 n.s. 
Akt - T308 1.212 + 0.171 1.320  + 0.089 
PLC-g1 - Y783 1.344 + 0.281 0.921 + 0.048 
p38a - T180Y182 1.411 + 0.240 1.156 + 0.138 
Data present mean + standard deviations of three independent experiments done on each 
HDL and ApoA-I. n.s. = not significant 
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7 Discussion  
To elucidate the itinerary of ApoA-I and HDL through endothelial cells (ECs), we 
investigated the cellular localization of ApoA-I and HDL. HDL as well as ApoA-I are taken 
up by ECs, and ApoA-I and HDL co-localize indicating the same route of trafficking. We 
compared the trafficking of ApoA-I and HDL with Transferrin and Albumin, which were 
used as tracers for clathrin- and caveolin-mediated endocytosis, respectively. Both 
pathways showed partial colocalization indicating a non-classical pathway for HDL 
trafficking. Further experiments showed that HDL is targeted neither to lysosomes nor to 
the Golgi nor to the endoplasmatic reticulum. Only a small amount can be detected in 
early endosomes (Rab5) and endosome to trans-golgi network (Rab9), but not at all with 
late endosomes (Rab7), the recycling endosomes (Rab11a) or vesicles involved in trans-
Golgi network sorting (Syntaxin6). EM ultrastructure showed HDL to be located mainly in 
multivesicular bodies. We performed pharmacological inhibitions and found that HDL 
uptake depends on intact cytoskeleton but not on fluid phase uptake. HDL was found to 
stimulate its own uptake into ECs. We identified several HDL and/or ApoA-I induced 
changes in the phosphorylation of signaling molecules, which however still remain to be 
linked to HDL endocytosis.  
 
7.1 Novel methodological developments 
As we did not figure out the identity of HDL containing vesicles by light microscopy, we 
decided to use electron microscopy to visualize them and get a glimpse on their 
ultrastructure. 1.4 nm nanogold and undecagold (Nanoprobes USA) as well as Aurora-
Gold-linked lipids (Avanti USA) are excellent tools for studying the cellular trafficking of 
proteins, small molecules, nanoparticles, lipid droplets, micelles, lipoproteins and lipid 
carrying proteins by electron microscopy. Because of their limited visibility by electron 
microscopy, they have not been extensively used. Rather, alternative methods like DAB 
photo oxidation through fluorescent labels (Dantuma et al. 1998) or larger labels like 
colloidal gold were used which however compromise spatial resolution and potentially 
interfere with the trafficking of the protein of interest.  
On-section silver enhancement of HDL in endothelial cells after HPF, FSF, and 
embedding in EA proved to be a suboptimal method for the detection of 1.4 nm nanogold, 
since the signal was extremely weak compared to fluorescent data. Morphew et al. 
(Morphew et al. 2008) were the first to establish a method to visualize nanogold particles 
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with an enhancement method during FSF allowing three dimensional EM studies of small 
tracers. However, the drawback of their volume enhancement method is the multitude of 
handling steps and the long enhancement time at two different temperatures.  
This led us develop the described short protocol for volume silver enhancement after FSF, 
which reduces the enhancement to effectively 30 minutes compared to 18 hours outlined 
in Morphews protocol (Figure 29). 
 
 
Figure 29: Fast volume enhancement after FSF 
 
The method is based on the classical silver enhancement approaches and Arabic gum 
was added as a protection colloid. With the Arabic gum present, the auto-nucleation and 
background signals were kept low on high pressure frozen samples of good quality. In 
badly frozen samples, silver nucleation was detected throughout the sample. The even 
distribution refers to distortion of the ultrastructure due to ice crystals generated during the 
freezing process.  
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In conclusion, we here present a novel sensitive and fast method for the visualization of 
lipid containing nanogold labeled particles in cells by TEM, which is compatible with HPF 
and FSF. This method opens new possibilities for the electron microscopic or tomographic 
analysis of nanogold labelled ligands within cells. It offers advantages in situations where 
lipid trafficking and lipid involvement is crucial. 
 
7.2 What is the trafficking route of HDL and ApoA-I in endothelial 
cells?  
To unravel the trafficking route of HDL and ApoA-I through ECs, we tried to co-localize 
HDL with vesicle and organelle markers as well as other proteins trafficking through ECs. 
We also explored effects of pharmacological inhibition on the trafficking of HDL through 
ECs.  
 
7.2.1 HDL co-localizes with lipid-free ApoA-I 
After 30 minutes HDL colocalizes perfectly with ApoA-I (Figure 4) when both are 
incubated with a monolayer of ECs either together or sequentially with a difference of 
some minutes. This is in agreement with the model previously established by our lab 
based on biochemical trafficking experiments using wild type and mutant ApoA-I (Ohnsorg 
et al. 2011). An ApoA-I mutant, which does not elicit ABCA1 dependent lipid efflux and 
therefore does not form HDL discs was not internalized by ECs. However after prior 
artificial lipidation, HDL discs containing the mutant ApoA-I were internalized. We 
therefore suggested that lipid-free ApoA-I is lipidated by ABCA1 to be internalized by the 
same route that artificial discoidal or native spherical HDL uses.  Based on this, we 
continued with our experiments with HDL as the object in study, as it behaves identical to 
ApoA-I.  
 
7.2.2 Time dependent trafficking of HDL through ECs 
Upon incubation for different time intervals, the fluorescent HDL changed its distribution 
within ECs (Figure 12). Initially few very weak signals appeared in the periphery of ECs as 
small vesicles. After 10 minutes the fluorescent HDL containg vesicles started clustering 
around the golgi at one side of the nucleus. This distribution is maintained from 30 min to 
about 3 hours. Thereafter the distribution becomes more peripheral. After 16 hours, more 
fluorescent HDL was detected on one side of the nucleus than in the periphery. At this 
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later time points the vesicles also appeared to be bigger than at shorter time points. Thus 
during a period ranging from 5 minutes to 16 hours, HDL resides in at least 3 different 
compartments of ECs. The nature of these HDL containing compartments needs to be 
defined.  
Endocytosis of GlycNAc labeled membrane proteins with fl-WGA was slower than HDL 
uptake (Figure 10). During the first 10 minutes we observed co-localization of HDL with 
WGA. During the following 20-30 minutes HDL and WGA accumulated in different golgi-
surrounding vesicles. From here, HDL was continuing its journey only after hours.  
Unfortunately we were not able to identify the compartment where HDL remained for 
hours by fluorescence microscopy since none of our organelle markers showed any co-
localization with HDL Therefore we switched to electron microscopy to analyse the 
vesicles, which contain HDL between 20 min and 4 h after uptake. The Au-HDL was 
mainly localized in multi vesicular bodies (MVB) where it was associated with the main 
membrane as well as the inner vesicles. Since MVBs are the main sorting stations of 
vesicular traffic, we assume that the HDL seen in fluorescence microscopy close to the 
golgi functions as a buffer or intermediate storage compartment for HDL transcytosis.  
 
7.2.3 Evidence for very fast transcytosis 
To analyse HDL transcytosis in temporal resolution, live microscopy experiments on cells 
cultured in transwells were performed. Surprisingly, while scanning at full speed the 
signals appeared both intracellularly in the ECs and below the ECs at the basolateral side. 
One to two volume sweeps (corresponding to 82 and164 seconds, respectively), after 
adding fl-HDL to the upper compartment of transwell plates containing a monolayer of 
ECs, signal could be detected below the EC layer (Figure 13). Only 10-15 minutes later 
vesicles lightened up inside ECs. Unfortunately, while being very good for light sectioning, 
the available confocal microscope was not fast and sensitive enough to detect fast weak 
signals of peripheral vesicles between zero and 82 seconds. However, the monolayer was 
still visibly intact and no signal could be detected in the junctions. Two alternative models 
can explain our findings:  
1. HDL may be trafficked through ECS by two parallel routes, one very fast leading to 
resecretion of HDL and one much slower leading to the accumulation of HDL within MVBs.  
2.  HDL is trafficked through one route and HDL accumulates in MVB’s if endocytosis is 
faster than exocytosis. To distinguish which model is true, we need access to fast live 3d 
microscopy and interfere with sorting processes inside the cell.  
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7.2.4 Role of clathrin. caveolae and fluid phase for HDL uptake by  
Both Albumin and Transferrin are internalized and resecreted by endothelial cells to 
supply sub-endothelial cells with their cargo, notably fatty acids and iron, respectively. 
HDL was partially co-localized with both Transferrin (Trf) and Albumin (Alb) (Figure 6 and 
Figure 7) indicating that their itinerary is overlapping with that of HDL. However the lack of 
complete co-localization indicates that they are not following the identical route. Albumin 
uptake depends on caveolin 1 and involves gp60 as the receptor (Geoffroy & Becker 
1984; Vogel et al. 2001). Transferrin was reported to pass the endothelium by both 
clathrin dependent and independent pathways (Kishimoto & Tavassoli 1987; Fishman et 
al. 1987; Roberts et al. 1993; Roberts & Sandra 1994; Tsuji et al. 2013). Transferrin 
interacts with the transferrin receptor for either endocytosis pathway.  
To test if HDL is internalized by clathrin or caveolin coated vesicles, we checked for co-
localization. At neither 37 °C nor 18 °C we observed any co-localization of HDL with 
clathrin and Caveolin 1 (Figure 5 C and D). In conjunction with the lack of complete 
colocalization between HDL, albumin and transferrin this indicates that HDL is internalized 
by ECs through a non-clathrin- and non-caveolin-dependent endocytic pathway. 
We suspected that HDL is taken up by fluid phase. The underlying pinocytosis does not 
require any defined receptor-ligand-interaction but is a bulk transport regulated 
independently of dynamin 2, clathrin and caveolin in epithelial cells (Cao et al. 2007). For 
example viruses are known to be internalized by pinocytosis (Mercer & Helenius 2009; 
Mercer & Helenius 2012). Interestingly, blocking of Na/H-channels essential for any fluid 
phase transport by Amiloride and/or EIPA even at high concentrations did not change 
HDL uptake (Figure 8 A-C). In addition we tried to co-localize fl-HDL with fluorescently 
labelled 40 kDa Dextran, which is taken up by cells through fluid phase endocytosis. We 
did not observe any co-localization of HDL and fl-Dextran (Figure 8 D-E). Taken together, 
these findings indicate that HDL is not taken up by fluid phase.  
 
7.2.5 HDL does not go to lysosomes 
Previous studies have shown that HDL is 10-20 fold less effectively degraded than LDL 
when incubated with endothelial cells (Tauber, Goldminz, Vlodavsky, et al. 1981). When 
cells need cholesterol or lipids, they can either synthetize it themselves, or increase 
uptake of lipoproteins. LDL is taken up by the LDL-receptor or LDL-Receptor like Protein 
family proteins (LRPs) and then transported to the lysosomes for degradation and delivery 
of lipids to other organelles. Only a part of LDL internalized by ECs is transported to 
lysosomes and degraded together with its receptor (Vasile et al. 1983). There are some 
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indications that a considerable part of LDL is transcytosed by ECs through caveolin 1 
containing vesicles (Bian et al. 2014). In fact, LDL found in the subendothelial space had 
to cross the endothelium. However this process is not well known. It is well possible that 
LDL crosses ECs by pathways avoiding the lysosomes similar to Trf and Alb and HDL. 
But for  
Biochemical turnover studies from our lab indicate that there is almost no degradation of 
HDL proteins in ECs (Rohrer et al. 2009b). In agreement with this and excluding any 
significant transport of HDL into lysosomes, we found no co-localization of fl-HDL with 
Lysotracker DND 99 (Figure 14). This non-lysosomal targeting is also indicated by the lack 
of any co-localization of HDL with Rab7, a marker for late endosomes (Figure 16) through 
which all classic traffic to lysosomes is channeled.  
The residence of a considerable proportion of HDL within ECs over a rather long period of 
time (Figure 12) without being degraded and secreted (Figure 13) indicates that HDL exerts 
functions while located intracellularly. Of special note HDL exerts many protective 
functions in endothelial cells. They are usually explained by extracellular interactions of 
HDL with ECs for example via cholesterol efflux or signaling events on the EC cell surface 
(Mineo & Shaul 2013; Annema & von Eckardstein 2013). But it will be interesting whether 
some depend on HDL internalization.  
 
7.2.6 No co-localization with organelles and main sorting vesicular pathways 
As after 30 minutes intracellular fl-HDL clusters close to one side of the nucleus, we 
suspected that it is transcytosed through the transgolgi network (TGN). However, staining 
the cells incubated with fl-HDL for Golgi58kDa protein and calnexin as markers for golgi 
and endoplasmatic reticulum (ER), respectively, revealed no co-localization (Figure 15). 
Neither did we see any co-localization with rab9 and syntaxin6 (Figure 18), both being 
involved in the trafficking to the TGN and golgi (Bock et al. 1997; Ng et al. 2012). This 
indicates, that HDL is localized in vesicles in close proximity to TGN, golgi or ER-golgi 
intermediate compartment (ERGIC) (Appenzeller-Herzog & Hauri 2006) but it is not 
directly crossing these metabolically active organelles of ECs.  
To further study the intinerary of HDL in ECs, we explored its co-localization with Rab5, 
the protein found on most endocytic endosomes, and Rab7, a marker for late endosomes. 
HDL failed to co-localize with either Rab5 or Rab7 after 30 minutes. Within shorter 
intervals, HDL positive vesicles were too faint for co-localization. This suggests that HDL 
passes the endosomes very quickly or in low amounts to accumulate in vesicles, which 
are rab5 and rab7 negative (Figure 16).  
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Rab11a is a marker for recycling vesicles transporting membrane and material coming 
from the apical surface back to the apical membrane. The Rab11a staining pattern was 
completely different from that of internalized fl-HDL (Figure 17), so that it is very unlikely 
that HDL travels through the recycling route. This is also in agreement with the trans-
endothelial transport that we observed by biochemical experiments (Rohrer et al. 2009b).  
 
7.2.7 HDL uptake and sorting depends on the cytoskeleton and dynamin  
The cytoskeleton is essential for any vesicular trafficking within the cell. Vesicles can be 
moved either by actin tails or kinesin-dynein driven movement across microtubule (DePina 
& Langford 1999). To analyse their impact on HDL uptake, we destabilized f-actin 
formation and blocked the generation of new actin fibers by cytochalasin D and disturbed 
microtubuli by colchicine. Both drugs affected the quantitative uptake of HDL slightly. 
However and unlike the interference with actin, the destruction of microtubules led to a 
gross change in the cellular distribution of HDL positive vesicles, which accumulated in 
peripheral rather than perinuclear compartments (Figure 19). It appears that the 
destruction of microtubule networks blocks the accumulation of HDL in MVB. This 
indicates, that HDL has to pass through endosomic vesicles before reaching MVBs.  
Dynamin aids the formation of vesicles by invagination from membranes by providing 
machinery for pinching off the newly formed vesicle from the original membrane. We 
tested the involvement of dynamin by blocking it pharmacologically with dynasore (Macia 
et al. 2006), an inhibitor of  dynamin activity and dynamin dependent vesicle formation. In 
our experiments dynasore treatment slightly reduced HDL uptake. Strikingly, however, 
dynamin shifted the distribution of HDL into smaller vesicles. This suggests that some 
essential sorting steps are blocked by dynasore or that the cell architecture in general was 
disturbed by the treatment (Figure 9). At 18 °C dynamin blockage by Dynasore led to the 
patchy accumulation of small vesicles close to the cell surface with much higher 
fluorescence signal than even the 37 °C internalized fl-HDLs and than we would expect to 
see. It could be that dynasore together with the temperature-lowered fluidity of 
membranes halts HDL internalization at one certain state and thereby favors the cellular 
accumulation of HDL.  
The PI3/4 Kinase inhibitor Wortmannin was another drug, which had significant effect on 
HDL uptake and distribution, ,. The uptake of HDL in the presence of Wortmannin was 
partially blocked (Figure 9) indicating that PI3/4K signaling was influencing the uptake of 
HDL or that HDL required a certain membrane distribution of PI3P, PI(3,4)P2 and 
PI(3,4,5)P3. It is well possible that downstream signaling of PI3K via Akt and TOR 
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signaling regulate HDL transport. Notably Akt is known to mediate many protective 
functions in ECs and to be activated by HDL, for example to activate eNOS and surpress 
VCAM1 cell surface expression (Mineo et al. 2003). The interaction of SR-BI with HDL 
which we previously found to modulate HDL transcytosis is known to signal via SR-BI-
PDZK-(?)-PI3K-Akt (Saddar et al. 2010) To analyse this hypothesis in a more targeted 
approach, it will be essential to investigate if HDL regulates its own uptake by ECs via 
PI3K/Akt signaling.  
 
 
7.3 What is the cellular localization of ABCA1, ABCG1, SR-BI and EL 
in endothelial cells? 
Indirect immunostainings of monolayers of ECs (Figure 23) and cryocuts of bovine aorta 
tissue (Figure 24) showed ABCA1, ABCG1, SR-BI and EL located intracellularly in 
vesicles but surprisingly not on the cell surface. Possibly there are low amounts of some 
of these proteins on the cell surface because reducing the expression levels of SR-BI, EL 
and ABCG1 by siRNA reduced 125I-HDL binding (Robert et al. 2013; Rohrer et al. 2009b). 
It is well possible that the amount of these proteins on the surface was too low for 
detection by indirect immunostaining. Alternatively these proteins participate in HDL 
binding indirectly by modulating another receptor. This may indicate that these interaction 
sites on ECs either are very few or recycle very rapidly upon binding of HDL between the 
plasma membrane and intracellular compartments. Alternatively, we did not choose the 
right HDL receptor candidates. For example CD36 and cubilin/megalin, endothelial lipase 
and SR-BI splice variants need further detection beyond immunostainings. Transfection 
with fluorescent fusion proteins may influence the localization and function of a protein in 
study but they give crucial information in live microscopy on the steady state as well as 
fast events upon possible binding of HDL on the cell surface.  
ABCA1 as well as F1-ATPase are interacting with lipid free ApoA-I, which is internalized 
only after lipidation.  
Hardly any SR-BI was detected on the surface of ECs, in contrast to hepatocytes, where 
substantial amounts of SR-BI are expressed (Fenske et al. 2009). It is possible that one of 
its splice variants, for example SR-B1.2, is responsible for HDL-binding and 
internalisation. SR-B1.2 contains a clathrin interaction signal but in contrast to SRB1.1 the 
clathrin signal is replacing the PDZK signaling domain (Eckhardt et al. 2006) SR-B1.1 is 
known to be expressed in ECs and to mediate cytoprotective effects of HDL via PDZK1. 
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By contrast SR-BI1.2 is not known to be expressed by ECs. Further elucidation of the 
exact role of SR-BI and its isoforms in ECs will be essential to better understand HDL 
trafficking.  
ABCG1 can probably be excluded for being a direct receptor for HDL as it has been 
shown in other cell types to act as a intracellular sterol transporter (Tarling & Edwards 
2011). We also failed to find ABCG1 on the surface of ECs by immunofluorescence. Also 
in our biochemical studies using radiolabelled 125i-HDL (Rohrer et al. 2009b) ABCG1 
knockdown limited HDL uptake to a greater extent than its binding. This may suggest 
ABCG1 regulates endocytosis via sterol distribution inside ECs. 
The ECs express an extensive glycokalyx, which can be several μm thick (Ebong et al. 
2011). The glycocalix can hinder endocytosis of extracellular molecules by prefiltering  
material before it gets into contact with the EC plasma membrane (Arkill et al. 2011; Arkill 
et al. 2012). However, it can also facilitate uptake by direct or indirect binding of the 
molecule to be internalized. A prominent example for facilitated uptake by direct binding is 
the association of LDL to proteoglycans, which enhances the uptake of LDL by the LDL 
receptor pathway. HDL is not directly bound by proteoglycans (Rinninger et al. 1998). 
However, EL is bound by proteoglycans which in turn tethers HDL on ECs (Strauss et al. 
2002; Jahangiri et al. 2005). In fact heparinase digestion as well as both inhibition and 
siRNA silencing of EL decreased both binding and transport of HDL through the ECs 
(Robert et al. 2013). Conversably binding and transport were increased by overexpression 
of wild type EL. Interestingly a catalytically inactive EL increased binding but not 
internalization and transport.  
 
7.4 How is the trafficking of HDL and ApoA-I modulated? 
Although our microscopy experiment showed no staining SR-BI on the surface, the 
presence of a blocking antibody against SR-BI or the SR-BI inhibitor BLT1 reduced the 
uptake of HDL into ECs (Figure 25). This is in agreement with our unpublished 
biochemical data showing reduced binding and uptake of HDL in the presence of BLT1 or 
siRNA or blocking antibodies against SR-BI.  
The lack of SR-BI localization by indirect immunofluorescence on the cell surface may be 
because only small amounts of SR-BI are involved in the trafficking of HDL or that the 
recycling and recruitment of SR-BI to the plasma membrane is fast and tightly regulated 
so that only few SR-BI molecules remain on the surface. After all, SR-BI is a cholesterol 
sensor and involved in lipid exchange (Saddar et al. 2013). Therefore ECs may prevent 
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themselves to receive or loose lipids to their environment, especially to the luminal side, in 
an uncontrolled way.  
Interestingly BLT1 was less potent than anti-SR-BI antibodies in inhibiting HDL uptake by 
ECs (Figure 25). One reason could be that the blockage of lipid transport by BLT1 is 
indirectly affecting SR-BI conformation and thereby influences the binding to HDL. 
Alternatively lipid transport via SR-BI is modulating the SR-BI independent uptake of HDL 
by another as yet unidentified receptor.  
With respect to the latter explanation it is noteworthy that pretreatment of ECs with 
competing amounts of HDL increased fl-HDL uptake significantly (Figure 26). Therefore 
and because both HDL and apoA-I are known to induce different signal transduction 
cascades in ECs, we systematically assessed the signaling elicited by HDL or lipid free 
ApoA-I in ECs. We used a phospho-kinase membrane array, to assess the 
phosphorylation of 43 kinases and two signaling molecules in ECs, which were incubated 
for 30 minutes with three different preparations of each HDL and apoA-I 
Nine and six phosphosites were significantly up- and downregulated, respectively, by all 
HDL preparations. In addition several phosophosites were incongruently regulated upon 
exposure to the three different HDL preparations resulting in high standard deviations if 
the data is taken together (Figure 27). 
ApoA-I up- and downregulated five and six phosphosites, respectively (Figure 28). 
Compared to HDL, the response to apoA-I was much less variable. The more variable and 
heterogenous response to HDL probably reflects the greater heterogeneity of HDL 
particles, which are known to function as platforms for many different hydrophobic 
molecules and to be prone to interindividual structural and functional variation (Annema & 
von Eckardstein 2013). Especially the inflammatory status of an individual is known to 
result in HDL changes and exert in “dysfunctional HDL”.  
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Figure 30: phosphosites regulated by HDL vs ApoA-I in ECs after 30 min stimulation: the orange 
boxes indicate possible complex formation and co-signaling. Red lines indicate the known activation 
of eNOS by akt or PLCg1 whereas the green line links the JAK-stat involved signaling complexes. Akt 
is also involved in PRAS40 and WNK1 signaling, as indicated by the dashed blue lines 
 
 
Among the consistently modulated signaling pathways, the phosphorylation of Wnt Kinase 
(WNT1) T60 was reduced by about 50 %in the presence of HDL. The same pathway was 
also triggered by ApoA-I although less strongly. Interestingly the WNT kinase pathway is 
activated by Akt, of which the regulatory sites S473 and T308 are downregulated by HDL 
and upregulated by HDL and ApoA-I, respectively. Akt is a very well known target of HDL 
signaling and is phosphorylated by PDK1, which is downstream of SR-BI. HDL/SR-BI  
interactions are known to elicit signaling through Src, PI3K and Akt as well as MAPK 
resulting in eNOS activation (Mineo et al. 2003). Furthermore the antiinflammatory and 
antiatherogenic properties of HDL associated lysosphingolipids are mediated by  
Akt/NFkB signaling (Schmidt et al. 2006). However, Akt signaling by HDL has not yet been 
associated with intracellular trafficking and endocytosis.   
The Wnt-beta-catenin pathway is highly conserved and involved in organogenesis during 
development (Akiyama 2000). ARF6 activation during Wnt signaling promotes 
internalization of growth factor receptors and activation of ERK signaling which 
destabilizes adherent junctions and lead to an increased pool of internal beta-catenin and 
E-catherin in epithelial cells (Pellon-Cardenas et al. 2013). The endocytic adapter 
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disabled-2 (DAB2), a known inhibitor of WNT/beta-catenin signaling recruits low-density 
lipoprotein receptor related protein 6 (LRP6) from its normal caveolin association for 
clathrin mediated endocytosis (Jiang et al. 2012). These signaling events are known to 
happen in development and stem cell maintenance. However as it is regulating the 
internalization of several growth factor receptors, it could be also affect HDL uptake. In 
endothelial cells endocytosis modulation by WNT/beta-catenin has not been much 
investigated. One group reported that endostatin is inducing autophagy in endothelial cells 
by reduction of the amount of beta-catenin (Nguyen et al. 2009). There is another report 
that the molecule wogonin is strongly inhibiting WNT/beta-catenin signaling in endothelial 
cells thereby modulating endothelial permeability (Song et al. 2013).  
Another group of signaling molecules modulated by HDL are SRC, PYK2, EGF receptor, 
PDGF receptor and PLC gamma 1 which all together are upstream of the focal adhesion 
kinase FAK1. SRC is known to be activated by HDL via SR-BI (Seetharam et al. 2006) via 
PDZK (Zhu et al. 2008) and to be involved in EC migration and growth. Its regulatory role 
for  uptake of HDL has not been investigated.  PYK2 is closely related to Src and FAK and 
involved in similar signaling cascades as it can for example compensate for FAK knock-
out (Sieg et al. 1998). In B lymphocytes PYK2 contributes to S1P induced signaling which 
can be disrupted by inhibition of PYK2 by its specific inhibitor FP-719 resulting in blocked 
migration (Tse et al. 2012). Together with Cas and FAK signaling PYK2 is also involved in 
Yersinia bacteria uptake (Bruce-Staskal et al. 2002). However it has not yet been 
associated with a ligand-receptor mediated uptake mechanism per se.  
Neither is it clear, if HDL mediated modulation of FAK1 modulates HDL uptake into ECs. 
Like PYK2 FAK has not yet been associated with endocytosis except that it is involved in 
integrin mediated uptake of bacteria (Alrutz & Isberg 1998; Bruce-Staskal et al. 2002). 
However, FAK is crucial for regulating endothelial permeability (Gavard & Gutkind 2008) 
cell growth and signaling in RhoA/ROCK pathways (Pirone et al. 2006) which itself is 
claimed to play a role in HDL uptake (Malaval et al. 2009). Interestingly this group of 
phosphosites is not much regulated by ApoA-I. Only the PDGF receptor signaling is 
upregulated by both HDL and ApoA-I. Phosphorylation of Y783 in PLC gamma 1 is even 
oppositely up-regulated by HDL but down-regulated by ApoA-I.  
The third group of HDL influenced phosphosites includes the STATs. HDL increased the 
phosphorylation of STAT2 Y689, STAT5b Y689 and STAT6 Y641 but decreased STAT3 
Y705. ApoA-I elicits  less prominent changes in the phosphorylation of STATs. However it 
also down-regulates the STAT3 Y727 site – which is the second regulatory site on STAT3 
(Wakahara et al. 2012). 
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One of the targets of STAT3 signaling is LCAT (Feister et al. 2002) which by itself 
regulates HDL concentrations in plasma as well as its composition (Kostner et al. 1987).  
It is however not known if STAT3 signaling is affecting HDL uptake directly. The 
phosphorylation of STAT2, STAT5 and STAT 6 was not changed upon ApoA-I incubation. 
STATs are integrating a bunch of signals, especially those elcited by cytokines and growth 
factors. G-CSF, GM-CSF, IL2, IL3, IL4, IL13, INFa, EPO and other stimuli will therefore 
need to be tested for possible modulation of HDL uptake to ECs. Interestingly, we 
previously found that IL6 stimulates the binding and transport of HDL trough ECs (Robert 
et al. 2013). IL6 signals through the JAK/STAT3 pathway. The downregulation of STAT3 
by HDL and ApoA-I may indicate a negative feedback regulation mechanism to tightly 
regulate EC stimulation by cytokines and their effect on HDL interaction and transport. 
Heat shock protein 27 S78 / S82 is downregulated by both HDL and ApoA-I. It is initiating 
the proteasome (Zhang et al. 2010) and is involved in apoptosis signaling (Acunzo et al. 
2012) as well as NF-ΚB modulation resulting e.g. in scavenger receptor A downregulation 
(Raizman et al. 2013). It has however not yet known that HDL or ApoA-I regulates HSP27. 
HSP27 is involved in exosome endocytosis (Svensson et al. 2013). 
We also observed a slight upregulation of eNOS S1177 by HDL but not ApoA-I, which is 
the activation site of eNOS. However eNOS S1177 is already strongly phosphorylated at 
baseline, so that HDL caused only a minor further enhancement. It has already been 
known that HDL induces the phosphorylation and activation of eNOS (Kuvin et al. 2002), 
(Rämet et al. 2003). However, it is unknown if eNOS regulates endocytosis in general or 
specifically HDL and ApoA-I endocytosis. 
Future research will have to unravel whether one or more of the signaling events 
modulated by HDL or apoA-I are related to the endocytosis of HDL. However, in view of 
the rapid endocytosis of HDL, it is also intriguing to ask, whether vice versa endocytosis of 
HDL is upstream of some observed alterations in the phosphorylation of kinases. 
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8 Conclusion and Outlook 
We here complemented our previous mostly biochemical experiments on the uptake and 
trafficking of HDL and ApoA-I in endothelial cell (EC) monolayers by systematic 
microscopic studies. We made the following major findings some of which will need 
elaboration by the proposed subsequent experiments:  
. 
I. In agreement with our previous results we found that HDL and ApoA-I are 
internalized and trafficked by ECs through the same route. This does not exclude 
that some lipids or specific proteins of HDL beyond are dissociating from the 
particle during its intracellular itinerary. Double labeling of the protein and lipid 
moieties for fluorescence microscopy would advance our knowledge. FRET of 
differently labeled lipids on HDL and on the ECs would give also insight on where 
they meet across its itinerary and interactions. For both fluorescence and electron 
microscopy, HDL should be reconstituted using distinct fluorescent lipids and 
Aurora-Nanogold-Lipids, respectively, for the lipid moiety, as well as different 
fluorescent dies and nanogold for the labeling of distinct proteins prior to 
reconstitution. 
II. Preliminary live confocal experiments (of limited temporal resolution) show that 
transcytosis of HDL through the EC monolayer is fast, so that the fluorescence 
was detected in the basolateral subendothelial matrix even before it started to 
appear in intracellular vesicles of ECs. We suggest doing sensitive high-speed live 
microscopy for getting more insight on early steps of HDL uptake. Reduced 
temperature live microscopy might give further insight. It also remains to be 
elucidated, if transcytosis of HDL and its uptake and storage are two interlinked 
processes or independent of each other. 
III. HDL fails to co-localize with ABCA1, ABCG1, SR-BI and EL, which were previously 
found by biochemical experiments to modulate transendothelial transport of ApoA-I 
and HDL. This supports our previous findings that these known HDL modulators 
do not directly mediate the uptake of HDL but indirectly modulate uptake by 
lipidating ApoA-I (ABCA1), changing the cellular cholesterol homeostasis or 
inducing signals which ultimately activate an as yet unidentified endocytic 
machinery for HDL uptake. Other candidates known to be expressed by 
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endothelial cells and to bind lipoproteins (for example CD36, LOX1) are worth to 
be investigated for their co-localization with HDL by fluorescence microscopy and 
for their involvement in HDL uptake by RNA interference experiments. Other 
candidates for example splice variants of SR-BI and megalin/cubilin have to be 
checked for their expression before structural and functional experiments are 
done. In the case of splice variants, gene constructs will have to be expressed for 
co-localization and functional experiments  
IV. Co-localization and pharmacological interference experiments make it unlikely that 
the classical clathrin- or caveolin 1-dependent endocytosis pathways or the fluid 
phase mediate the uptake of HDL into ECs. We identified at least three time-
dependent subcellular distributions of HDL positive vesicles over a period of 5 
minutes to 16 hours. Electron microscopy experiments indicate that HDL is 
effectively sorted through multivesicular bodies (MVB). HDL does not go to 
lysosomes and is not degraded for up to 4 hours. HDL was co-localized with 
neither Rab5, Rab7, Rab9, Syntaxin6 nor endoplasmatic reticulum nor golgi. We 
could however co-localize HDL with WGA at specific times and there is partial 
overlapping of HDL trafficking with Transferrin and Albumin. Taken together, HDL 
seems to use atypical entry pathways into ECs but is sorted into common places 
where also Transferrin and Albumin pass through. To definitely rule out the 
contribution of clathrin and caveolin-1 it will be important to investigate the uptake 
of HDL by ECs from knock-out mice lacking clathrin adapter proteins like AP2 and 
caveolin-1, respectively. 
V. Interferences with the cytoskeleton, dynamins, or PI3/4 Kinases did not prevent 
quantitative HDL uptake but modulated sorting qualitatively. It will be interesting to 
characterize the altered vesicular distribution by a novel series of co-localization 
and electron microscopy studies. Biochemical binding, internalization and transport 
experiments may help to find blockages in the re-secretion of HDL  
VI. Finally HDL was found to stimulate its own uptake into ECs. Our subsequent 
screening identified several HDL and/or apoA-I induced changes in the 
phosphorylation of signaling molecules including some, which were already known 
to be modulated by HDL or apoA-I like Akt or eNOS. Others were unknown 
reactants to HDL or apoA-I. To prove or disprove the involvement of these signal 
transduction pathways in transendothelial transport of HDL requires 
pharmacological and genetic interference experiments.  
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